CSF1R
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
Y Sites Probabilities
Log-Odds: Y Sites / Y Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A1L429 | Y10 | Sugiyama | GAGE12B; GAGE12C; GAGE12D; GAGE12E | ___________MSWRGRsTyyWPRPRRYVQPPEMIGPMRPE |
| A1L429 | Y9 | Sugiyama | GAGE12B; GAGE12C; GAGE12D; GAGE12E | ____________MSWRGRsTyyWPRPRRYVQPPEMIGPMRP |
| A1X283 | Y855 | Sugiyama | SH3PXD2B FAD49 KIAA1295 TKS4 | NREKAAAASVPNADGLKDSLyVAVADFEGDKDTSSFQEGTV |
| A5A3E0 | Y1062 | Sugiyama | POTEF A26C1B | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCL_______ |
| A5A3E0 | Y940 | Sugiyama | POTEF A26C1B | ALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPEA |
| A6NDE8 | Y10 | Sugiyama | GAGE12H | ___________MSWRGRsTyyWPRPRRYVQPPEMIGPMRPE |
| A6NDE8 | Y9 | Sugiyama | GAGE12H | ____________MSWRGRsTyyWPRPRRYVQPPEMIGPMRP |
| A6NER3 | Y10 | Sugiyama | GAGE12J | ___________MSWRGRsTyyWPRPRPYVQPPEMIGPMRPE |
| A6NER3 | Y9 | Sugiyama | GAGE12J | ____________MSWRGRsTyyWPRPRPYVQPPEMIGPMRP |
| A6NMY6 | Y147 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | sLIEIICsRtNQELQEINRVyKEMYKtDLEKDIIsDtsGDF |
| A6NMY6 | Y235 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | sIMTERSVPHLQKVFDRYKsysPyDMLEsIRKEVKGDLENA |
| A6NMY6 | Y238 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | TERSVPHLQKVFDRYKsysPyDMLEsIRKEVKGDLENAFLN |
| A6NMY6 | Y333 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | KsLyyyIQQDTKGDyQKALLyLCGGDD______________ |
| O00116 | Y645 | Sugiyama | AGPS AAG5 | QWLKESIsDVGFGMLKSVKEyVDPNNIFGNRNLL_______ |
| O00193 | Y84 | Sugiyama | SMAP C11orf58 | TSHFRTGEEDKKINEELEsQyQQsMDsKLSGRYRRHCGLGF |
| O00264 | Y113 | Sugiyama | PGRMC1 HPR6.6 PGRMC | INGKVFDVTKGRKFyGPEGPyGVFAGRDASRGLATFCLDKE |
| O00299 | Y233 | Sugiyama | CLIC1 G6 NCC27 | AyAREEFAstCPDDEEIELAyEQVAKALK____________ |
| O00429 | Y101 | Sugiyama | DNM1L DLP1 DRP1 | EENGVEAEEWGKFLHTKNKLyTDFDEIRQEIENETERISGN |
| O00571 | Y38 | Sugiyama | DDX3X DBX DDX3 | GLDLNssDNQsGGstAsKGRyIPPHLRNREATKGFyDKDSS |
| O00625 | Y131 | Sugiyama | PIR | AHGLQLWVNLRSSEKMVEPQyQELKSEEIPKPSKDGVTVAV |
| O14818 | T147 | Sugiyama | PSMA7 HSPC | FGISALIVGFDFDGTPRLyQtDPsGtyHAWKANAIGRGAKS |
| O14818 | T152 | Sugiyama | PSMA7 HSPC | LIVGFDFDGTPRLyQtDPsGtyHAWKANAIGRGAKSVREFL |
| O14818 | Y145 | Sugiyama | PSMA7 HSPC | RPFGISALIVGFDFDGTPRLyQtDPsGtyHAWKANAIGRGA |
| O14818 | Y153 | Sugiyama | PSMA7 HSPC | IVGFDFDGTPRLyQtDPsGtyHAWKANAIGRGAKSVREFLE |
| O14818 | Y176 | Sugiyama | PSMA7 HSPC | WKANAIGRGAKSVREFLEKNyTDEAIETDDLTIKLVIKALL |
| O14950 | Y156 | Sugiyama | MYL12B MRLC2 MYLC2B | DEEVDELyREAPIDKKGNFNyIEFtRILKHGAKDKDD____ |
| O14974 | Y901 | Sugiyama | PPP1R12A MBS MYPT1 | EtQtDsIsRyETssTsAGDRyDsLLGRsGsysYLEERKPYS |
| O14980 | Y463 | Sugiyama | XPO1 CRM1 | EFMKDTDsINLyKNMRETLVyLTHLDyVDTERIMTEKLHNQ |
| O14980 | Y469 | Sugiyama | XPO1 CRM1 | DsINLyKNMRETLVyLTHLDyVDTERIMTEKLHNQVNGTEW |
| O15013 | Y1307 | Sugiyama | ARHGEF10 KIAA0294 | sLsLsHGsssLEHRSEDsTIyDLLKDPVSLRSKARRAKKAK |
| O15067 | Y538 | Sugiyama | PFAS KIAA0361 | GAGGNGNVLKELsDPAGAIIytsRFQLGDPTLNALEIWGAE |
| O15226 | Y682 | Sugiyama | NKRF ITBA4 NRF | RKRRKEDLLDQLKQEGQVGHyELVMPQAN____________ |
| O15230 | Y81 | Sugiyama | LAMA5 KIAA0533 KIAA1907 | SATCGEEAPARGSPRPTEDLyCKLVGGPVAGGDPNQTIRGQ |
| O15234 | Y240 | Sugiyama | CASC3 MLN51 | HDKFREDEQAPKSRQELIALyGyDIRSAHNPDDIKPRRIRK |
| O15234 | Y242 | Sugiyama | CASC3 MLN51 | KFREDEQAPKSRQELIALyGyDIRSAHNPDDIKPRRIRKPR |
| O15305 | Y205 | Sugiyama | PMM2 | DGWDKRYCLRHVENDGYKTIyFFGDKTMPGGNDHEIFTDPR |
| O15357 | Y1135 | Sugiyama | INPPL1 SHIP2 | SGDDRSCSVLQMAKTLSEVDyAPAGPARSALLPGPLELQPP |
| O15371 | Y50 | Sugiyama | EIF3D EIF3S7 | yQPFsKGDRLGKVADWtGAtyQDKRYTNKYSSQFGGGSQYA |
| O15523 | Y38 | Sugiyama | DDX3Y DBY | NLDLNSEKQSGGASTASKGRyIPPHLRNREASKGFHDKDSS |
| O43172 | Y31 | Sugiyama | PRPF4 PRP4 | ATKTKAPDDLVAPVVKKPHIyyGsLEEKERERLAKGESGIL |
| O43172 | Y32 | Sugiyama | PRPF4 PRP4 | TKTKAPDDLVAPVVKKPHIyyGsLEEKERERLAKGESGILG |
| O43390 | Y136 | Sugiyama | HNRNPR HNRPR | QESTKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVY |
| O43390 | Y376 | Sugiyama | HNRNPR HNRPR | ILEKSFSEFGKLERVKKLKDyAFVHFEDRGAAVKAMDEMNG |
| O43390 | Y435 | Sugiyama | HNRNPR HNRPR | KRKERQAARQAsRstAyEDyyyHPPPRMPPPIRGRGRGGGR |
| O43390 | Y436 | Sugiyama | HNRNPR HNRPR | RKERQAARQAsRstAyEDyyyHPPPRMPPPIRGRGRGGGRG |
| O43615 | Y201 | Sugiyama | TIMM44 MIMT44 TIM44 | QGVEsVKKEIDDsVLGQtGPyRRPQRLRKRTEFAGDKFKEE |
| O43707 | Y212 | Sugiyama | ACTN4 | WKDGLAFNALIHRHRPELIEyDKLRKDDPVTNLNNAFEVAE |
| O43707 | Y234 | Sugiyama | ACTN4 | KLRKDDPVTNLNNAFEVAEKyLDIPKMLDAEDIVNtARPDE |
| O43707 | Y878 | Sugiyama | ACTN4 | DKNFITAEELRRELPPDQAEyCIARMAPyQGPDAVPGALDy |
| O43823 | Y311 | Sugiyama | AKAP8 AKAP95 | RGFDRFGPDGTGRKRKQFQLyEEPDtKLARVDsEGDFsEND |
| O43852 | Y106 | Sugiyama | CALU | GFVtVDELKDWIKFAQKRWIyEDVERQWKGHDLNEDGLVsW |
| O43852 | Y185 | Sugiyama | CALU | KDGDLIATKEEFtAFLHPEEyDyMKDIVVQEtMEDIDKNAD |
| O43852 | Y187 | Sugiyama | CALU | GDLIATKEEFtAFLHPEEyDyMKDIVVQEtMEDIDKNADGF |
| O43852 | Y263 | Sugiyama | CALU | KNRDGKMDKEEtKDWILPsDyDHAEAEARHLVyEsDQNKDG |
| O43852 | Y47 | Sugiyama | CALU | RVHHEPQLsDKVHNDAQsFDyDHDAFLGAEEAKtFDQLtPE |
| O60264 | Y141 | Sugiyama | SMARCA5 SNF2H WCRF135 | KPGRPRIKKDEKQNLLsVGDyRHRRTEQEEDEELLTEsSKA |
| O60361 | Y136 | Sugiyama | NME2P1 | SLRFKPEELVDYKSCAHDWVyE___________________ |
| O60488 | Y582 | Sugiyama | ACSL4 ACS4 FACL4 LACS4 | DGCLQIIDRKKDLVKLQAGEyVsLGKVEAALKNCPLIDNIC |
| O60493 | Y71 | Sugiyama | SNX3 | IRVKTNLPIFKLKESTVRRRysDFEWLRSELERESKVVVPP |
| O60506 | Y133 | Sugiyama | SYNCRIP HNRPQ NSAP1 | ADSSKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVY |
| O60506 | Y373 | Sugiyama | SYNCRIP HNRPQ NSAP1 | ILEKAFsQFGKLERVKKLKDyAFIHFDERDGAVKAMEEMNG |
| O60664 | Y235 | Sugiyama | PLIN3 M6PRBP1 TIP47 | AtsLDGFDVAsVQQQRQEQSyFVRLGsLSERLRQHAyEHsL |
| O60664 | Y95 | Sugiyama | PLIN3 M6PRBP1 TIP47 | VsGAQPILSKLEPQIAsAsEyAHRGLDKLEENLPILQQPTE |
| O60716 | Y228 | Sugiyama | CTNND1 KIAA0384 | yPPDGysRHyEDGyPGGsDNyGsLsRVtRIEERyRPsMEGy |
| O60739 | Y30 | Sugiyama | EIF1B | FDPFADATKGDDLLPAGTEDyIHIRIQQRNGRKtLttVQGI |
| O60814 | Y41 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| O60814 | Y43 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| O60841 | S186 | Sugiyama | EIF5B IF2 KIAA0741 | EDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKKNQKN |
| O60927 | Y64 | Sugiyama | PPP1R11 HCGV TCTE5 | TsDTVDNEHMGRRssKCCCIyEKPRAFGEsstEsDEEEEEG |
| O75116 | Y936 | Sugiyama | ROCK2 KIAA0619 | EITLTKADSEQLARsIAEEQysDLEKEKIMKELEIKEMMAR |
| O75223 | Y156 | Sugiyama | GGCT C7orf24 CRF21 | sPQYKKIICMGAKENGLPLEyQEKLKAIEPNDytGKVsEEI |
| O75347 | Y75 | Sugiyama | TBCA | EILQEsRMMIPDCQRRLEAAyLDLQRILENEKDLEEAEEyK |
| O75348 | Y47 | Sugiyama | ATP6V1G1 ATP6G ATP6G1 ATP6J | KRKNRRLKQAKEEAQAEIEQyRLQREKEFKAKEAAALGsRG |
| O75533 | Y152 | Sugiyama | SF3B1 SAP155 | RLDPFADGGKtPDPKMNARTyMDVMREQHLTKEEREIRQQL |
| O75683 | Y10 | Sugiyama | SURF6 SURF-6 | ___________MASLLAKDAyLQsLAKKICSHsAPEQQART |
| O76087 | Y10 | Sugiyama | GAGE7 GAGE12I GAGE7B | ___________MSWRGRsTyyWPRPRRYVQPPEMIGPMRPE |
| O76087 | Y9 | Sugiyama | GAGE7 GAGE12I GAGE7B | ____________MSWRGRsTyyWPRPRRYVQPPEMIGPMRP |
| O94906 | Y105 | Sugiyama | PRPF6 C20orf14 | AGSLFSSGPYEKDDEEADAIyAALDKRMDERRKERREQREK |
| O95218 | Y114 | Sugiyama | ZRANB2 ZIS ZNF265 | AKLEERtGYGGGFNERENVEyIEREEsDGEyDEFGRKKKKY |
| O95218 | Y124 | Sugiyama | ZRANB2 ZIS ZNF265 | GGFNERENVEyIEREEsDGEyDEFGRKKKKYRGKAVGPAsI |
| O95218 | Y167 | Sugiyama | ZRANB2 ZIS ZNF265 | EVEDKEsEGEEEDEDEDLsKyKLDEDEDEDDADLsKyNLDA |
| O95295 | Y81 | Sugiyama | SNAPIN BLOC1S7 SNAP25BP SNAPAP | LATELCRINEDQKVALDLDPyVKKLLNARRRVVLVNNILQN |
| O95297 | Y263 | Sugiyama | MPZL1 PZR UNQ849/PRO1787 | QLDHsGGHHSDKINKSEsVVyADIRKN______________ |
| O95347 | Y938 | Sugiyama | SMC2 CAPE SMC2L1 PRO0324 | SKHKREAEDGAAKVSKMLKDyDWINAERHLFGQPNSAYDFK |
| O95425 | Y132 | Sugiyama | SVIL | RRRQLAEKyGLTLDPEADsEyLsRYTKSRKEPDAVEKRGGK |
| O95573 | Y591 | Sugiyama | ACSL3 ACS3 FACL3 LACS3 | DGCLKIIDRKKDLVKLQAGEyVsLGKVEAALKNLPLVDNIC |
| O95757 | Y627 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | MIMQDKLEKERNDAKNAVEEyVyDFRDRLGtVYEKFITPED |
| O95757 | Y629 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | MQDKLEKERNDAKNAVEEyVyDFRDRLGtVYEKFITPEDLS |
| O95881 | Y137 | Sugiyama | TXNDC12 TLP19 UNQ713/PRO1376 | FLDPSGKVHPEIINENGNPsyKyFyVsAEQVVQGMKEAQER |
| O96019 | Y68 | Sugiyama | ACTL6A BAF53 BAF53A INO80K | DDGsTLMEIDGDKGKQGGPtyyIDtNALRVPRENMEAIsPL |
| O96019 | Y69 | Sugiyama | ACTL6A BAF53 BAF53A INO80K | DGsTLMEIDGDKGKQGGPtyyIDtNALRVPRENMEAIsPLK |
| P00338 | Y10 | Sugiyama | LDHA PIG19 | ___________MAtLKDQLIyNLLKEEQtPQNKITVVGVGA |
| P00338 | Y239 | Sugiyama | LDHA PIG19 | GtDKDKEQWKEVHKQVVEsAyEVIKLKGYtSWAIGLSVADL |
| P00491 | Y166 | Sugiyama | PNP NP | PLRGPNDERFGDRFPAMsDAyDRtMRQRALstWKQMGEQRE |
| P00505 | Y96 | Sugiyama | GOT2 KYAT4 | VLPSVRKAEAQIAAKNLDKEyLPIGGLAEFCKASAELALGE |
| P00558 | Y161 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | KAEPAKIEAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNL |
| P00558 | Y196 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | MVGVNLPQKAGGFLMKKELNyFAKALEsPERPFLAILGGAK |
| P00966 | Y163 | Sugiyama | ASS1 ASS | APWRMPEFYNRFKGRNDLMEyAKQHGIPIPVtPKNPWSMDE |
| P02786 | Y152 | Sugiyama | TFRC | sEKLDstDFTGtIKLLNENsyVPREAGsQKDENLALyVENQ |
| P02786 | Y402 | Sugiyama | TFRC | KEIKILNIFGVIKGFVEPDHyVVVGAQRDAWGPGAAKSGVG |
| P04080 | Y97 | Sugiyama | CSTB CST6 STFB | NKPLtLsNyQTNKAKHDELtyF___________________ |
| P04181 | Y50 | Sugiyama | OAT | TKKtVQGPPtSDDIFEREyKyGAHNyHPLPVALERGKGIyL |
| P04181 | Y55 | Sugiyama | OAT | QGPPtSDDIFEREyKyGAHNyHPLPVALERGKGIyLWDVEG |
| P04406 | Y314 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | tFDAGAGIALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsK |
| P04406 | Y320 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GIALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsKE_____ |
| P04920 | Y73 | Sugiyama | SLC4A2 AE2 EPB3L1 HKB3 MPB3L | EAGsRGGEEPGRsYGEEDFEyHRQSSHHIHHPLSTHLPPDA |
| P05362 | Y455 | Sugiyama | ICAM1 | GtFPLPIGEsVtVtRDLEGtyLCRARSTQGEVTRKVTVNVL |
| P05455 | Y104 | Sugiyama | SSB | EDKTKIRRsPsKPLPEVTDEyKNDVKNRsVYIKGFPtDAtL |
| P05787 | Y204 | Sugiyama | KRT8 CYK8 | NKRTEMENEFVLIKKDVDEAyMNKVELESRLEGLTDEINFL |
| P05787 | Y282 | Sugiyama | KRT8 CYK8 | EVKAQyEDIANRsRAEAEsMyQIKyEELQsLAGKHGDDLRR |
| P06733 | S272 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | FRsGKyDLDFKsPDDPsRyIsPDQLADLyKsFIKDyPVVsI |
| P06733 | Y189 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | MILPVGAANFREAMRIGAEVyHNLKNVIKEKyGKDAtNVGD |
| P06733 | Y270 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | EFFRsGKyDLDFKsPDDPsRyIsPDQLADLyKsFIKDyPVV |
| P06733 | Y280 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | DFKsPDDPsRyIsPDQLADLyKsFIKDyPVVsIEDPFDQDD |
| P06733 | Y287 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | PsRyIsPDQLADLyKsFIKDyPVVsIEDPFDQDDWGAWQKF |
| P06733 | Y44 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | LFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKGVSK |
| P06899 | Y41 | Sugiyama | H2BC11 H2BFR HIST1H2BJ | KAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISSKAMG |
| P06899 | Y43 | Sugiyama | H2BC11 H2BFR HIST1H2BJ | QKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISSKAMGIM |
| P07195 | Y240 | Sugiyama | LDHB | GTDNDSENWKEVHKMVVEsAyEVIKLKGYTNWAIGLSVADL |
| P07205 | Y161 | Sugiyama | PGK2 PGKB | KAEPDKIEAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNL |
| P07237 | Y94 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | GSEIRLAKVDAtEEsDLAQQyGVRGyPtIKFFRNGDTASPK |
| P07237 | Y99 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | LAKVDAtEEsDLAQQyGVRGyPtIKFFRNGDTASPKEytAG |
| P07333 | S555 | Sugiyama | CSF1R FMS | LLLYKYKQKPKyQVRWKIIEsyEGNSyTFIDPTQLPyNEKW |
| P07333 | S688 | Sugiyama | CSF1R FMS | YGDLLNFLRRKAEAMLGPSLsPGQDPEGGVDyKNIHLEKKy |
| P07333 | S807 | Sugiyama | CSF1R FMS | TNGHVAKIGDFGLARDIMNDsNyIVKGNARLPVKWMAPESI |
| P07333 | Y546 | GPS6|EPSD|PSP | CSF1R FMS | MALLLLLLLLLLYKYKQKPKyQVRWKIIEsyEGNSyTFIDP |
| P07333 | Y556 | Sugiyama | CSF1R FMS | LLYKYKQKPKyQVRWKIIEsyEGNSyTFIDPTQLPyNEKWE |
| P07333 | Y561 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP|Sugiyama | CSF1R FMS | KQKPKyQVRWKIIEsyEGNSyTFIDPTQLPyNEKWEFPRNN |
| P07333 | Y571 | Sugiyama | CSF1R FMS | KIIEsyEGNSyTFIDPTQLPyNEKWEFPRNNLQFGKTLGAG |
| P07333 | Y699 | GPS6|SIGNOR|EPSD|PSP|Sugiyama | CSF1R FMS | AEAMLGPSLsPGQDPEGGVDyKNIHLEKKyVRRDSGFsSQG |
| P07333 | Y708 | GPS6|SIGNOR|EPSD | CSF1R FMS | sPGQDPEGGVDyKNIHLEKKyVRRDSGFsSQGVDTyVEMRP |
| P07333 | Y723 | GPS6|SIGNOR|EPSD | CSF1R FMS | HLEKKyVRRDSGFsSQGVDTyVEMRPVSTSSNDSFSEQDLD |
| P07333 | Y809 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP|Sugiyama | CSF1R FMS | GHVAKIGDFGLARDIMNDsNyIVKGNARLPVKWMAPESIFD |
| P07333 | Y873 | Sugiyama | CSF1R FMS | LNPYPGILVNSKFYKLVKDGyQMAQPAFAPKNIYSIMQACW |
| P07333 | Y923 | GPS6|EPSD | CSF1R FMS | FQQICSFLQEQAQEDRRERDyTNLPSSSRSGGSGSSSSELE |
| P07333 | Y969 | GPS6|SIGNOR|EPSD | CSF1R FMS | EHLTCCEQGDIAQPLLQPNNyQFC_________________ |
| P07355 | S184 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | sGDFRKLMVALAKGRRAEDGsVIDyELIDQDARDLyDAGVK |
| P07355 | Y147 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | sLIEIICsRtNQELQEINRVyKEMYKtDLEKDIIsDtsGDF |
| P07355 | Y188 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | RKLMVALAKGRRAEDGsVIDyELIDQDARDLyDAGVKRKGT |
| P07355 | Y235 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | sIMTERSVPHLQKVFDRYKsysPyDMLEsIRKEVKGDLENA |
| P07355 | Y238 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | TERSVPHLQKVFDRYKsysPyDMLEsIRKEVKGDLENAFLN |
| P07355 | Y333 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | KsLyyyIQQDTKGDyQKALLyLCGGDD______________ |
| P07437 | Y50 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | IDPTGtyHGDsDLQLDRIsVyyNEAtGGKyVPRAILVDLEP |
| P07437 | Y51 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | DPTGtyHGDsDLQLDRIsVyyNEAtGGKyVPRAILVDLEPG |
| P07711 | Y112 | Sugiyama | CTSL CTSL1 | MNGFQNRKPRKGKVFQEPLFyEAPRSVDWREKGyVTPVKNQ |
| P07711 | Y311 | Sugiyama | CTSL CTSL1 | DNNKYWLVKNsWGEEWGMGGyVKMAKDRRNHCGIAsAAsyP |
| P07711 | Y330 | Sugiyama | CTSL CTSL1 | GyVKMAKDRRNHCGIAsAAsyPtV_________________ |
| P07814 | Y1504 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | KPLCELQPGAKCVCGKNPAKyytLFGRsy____________ |
| P07814 | Y1505 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | PLCELQPGAKCVCGKNPAKyytLFGRsy_____________ |
| P07814 | Y754 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | ERPtPsLNNNCttsEDsLVLyNRVAVQGDVVRELKAKKAPK |
| P07814 | Y827 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | EIGQNIssNssAsILESKsLyDEVAAQGEVVRKLKAEKSPK |
| P07858 | Y244 | Sugiyama | CTSB CPSB | HYGYNSYSVSNSEKDIMAEIyKNGPVEGAFSVYSDFLLYKS |
| P07900 | Y160 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | SAYLVAEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGEPM |
| P07900 | Y284 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DEEEEKKDGDKKKKKKIKEKyIDQEELNKtKPIWtRNPDDI |
| P07900 | Y309 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | ELNKtKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHF |
| P07900 | Y313 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | tKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHFSVEG |
| P07900 | Y492 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DEMVsLKDYCTRMKENQKHIyyItGETKDQVANsAFVERLR |
| P07900 | Y493 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | EMVsLKDYCTRMKENQKHIyyItGETKDQVANsAFVERLRK |
| P07900 | Y61 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | KEIFLRELIsNssDALDKIRyEsLtDPsKLDsGKELHINLI |
| P07954 | Y110 | Sugiyama | FH | tPVIKAFGILKRAAAEVNQDyGLDPKIANAIMKAADEVAEG |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | Y155 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | SAYLVAEKVVVITKHNDDEQyAWEssAGGsFtVRADHGEPI |
| P08238 | Y276 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DEEDDsGKDKKKKTKKIKEKyIDQEELNKtKPIWtRNPDDI |
| P08238 | Y301 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | ELNKtKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHF |
| P08238 | Y305 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | tKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHFSVEG |
| P08238 | Y472 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | sELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItGEsKE |
| P08238 | Y484 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DEMtsLsEyVsRMKEtQKsIyyItGEsKEQVANsAFVERVR |
| P08238 | Y485 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | EMtsLsEyVsRMKEtQKsIyyItGEsKEQVANsAFVERVRK |
| P08238 | Y56 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KEIFLRELIsNAsDALDKIRyEsLtDPsKLDsGKELKIDII |
| P08238 | Y619 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | TANMERIMKAQALRDNstMGyMMAKKHLEINPDHPIVEtLR |
| P08670 | Y291 | Sugiyama | VIM | DVRQQyEsVAAKNLQEAEEWyKSKFADLsEAANRNNDALRQ |
| P08708 | Y84 | Sugiyama | RPS17 RPS17L | GPVRGISIKLQEEERERRDNyVPEVsALDQEIIEVDPDtKE |
| P08758 | S135 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | AsRtPEELRAIKQVyEEEyGssLEDDVVGDTSGYYQRMLVV |
| P09234 | Y8 | Sugiyama | SNRPC | _____________MPKFyCDyCDtyLtHDsPsVRKTHCSGR |
| P09651 | Y341 | Sugiyama | HNRNPA1 HNRPA1 | QSSNFGPMKGGNFGGRssGPyGGGGQyFAKPRNQGGyGGss |
| P09651 | Y347 | Sugiyama | HNRNPA1 HNRPA1 | PMKGGNFGGRssGPyGGGGQyFAKPRNQGGyGGssssssyG |
| P09769 | Y208 | Sugiyama | FGR SRC2 | DQTRGDHVKHYKIRKLDMGGyyItTRVQFNSVQELVQHYME |
| P09769 | Y209 | Sugiyama | FGR SRC2 | QTRGDHVKHYKIRKLDMGGyyItTRVQFNSVQELVQHYMEV |
| P0CG38 | Y1062 | Sugiyama | POTEI | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P0CG39 | Y1025 | Sugiyama | POTEJ | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P0CL80 | Y10 | Sugiyama | GAGE12F | ___________MSWRGRsTyyWPRPRRYVQPPEMIGPMRPE |
| P0CL80 | Y9 | Sugiyama | GAGE12F | ____________MSWRGRsTyyWPRPRRYVQPPEMIGPMRP |
| P0DPH7 | T225 | Sugiyama | TUBA3C TUBA2 | DNEAIYDICRRNLDIERPtytNLNRLIGQIVSSITASLRFD |
| P0DSO3 | Y10 | Sugiyama | GAGE4 | ___________MSWRGRsTyyWPRPRRYVQPPEMIGPMRPE |
| P0DSO3 | Y9 | Sugiyama | GAGE4 | ____________MSWRGRsTyyWPRPRRYVQPPEMIGPMRP |
| P10398 | Y155 | Sugiyama | ARAF ARAF1 PKS PKS2 | HCSSKVPTVCVDMSTNRQQFyHsVQDLsGGsRQHEAPsNRP |
| P10809 | Y223 | Sugiyama | HSPD1 HSP60 | DGKtLNDELEIIEGMKFDRGyIsPyFINtsKGQKCEFQDAy |
| P10809 | Y227 | Sugiyama | HSPD1 HSP60 | LNDELEIIEGMKFDRGyIsPyFINtsKGQKCEFQDAyVLLs |
| P10809 | Y243 | Sugiyama | HSPD1 HSP60 | yIsPyFINtsKGQKCEFQDAyVLLsEKKIssIQsIVPALEI |
| P11047 | Y352 | Sugiyama | LAMC1 LAMB2 | tAEsASECLPCDCNGRsQECyFDPELyRSTGHGGHCTNCQD |
| P11142 | Y41 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P11142 | Y431 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | TVLIKRNtTIPTKQtQtFttysDNQPGVLIQVyEGERAMTK |
| P11142 | Y443 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | KQtQtFttysDNQPGVLIQVyEGERAMTKDNNLLGKFELTG |
| P11142 | Y545 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | YKAEDEKQRDKVssKNsLEsyAFNMKATVEDEKLQGKINDE |
| P11413 | Y118 | Sugiyama | G6PD | LEDFFARNsyVAGQyDDAAsyQRLNsHMNALHLGsQANRLF |
| P11940 | Y194 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | KSRKEREAELGARAKEFtNVyIKNFGEDMDDERLKDLFGKF |
| P11940 | Y291 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | ERQTELKRKFEQMKQDRITRyQGVNLyVKNLDDGIDDERLR |
| P11940 | Y297 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | KRKFEQMKQDRITRyQGVNLyVKNLDDGIDDERLRKEFsPF |
| P12268 | Y509 | Sugiyama | IMPDH2 IMPD2 | KFEKRtssAQVEGGVHsLHsyEKRLF_______________ |
| P12277 | Y125 | Sugiyama | CKB CKBB | EHKTDLNPDNLQGGDDLDPNyVLssRVRTGRSIRGFCLPPH |
| P12277 | Y39 | Sugiyama | CKB CKBB | EFPDLSAHNNHMAKVLtPELyAELRAKSTPSGFTLDDVIQT |
| P12814 | Y215 | Sugiyama | ACTN1 | KLRKDDPLTNLNTAFDVAEKyLDIPKMLDAEDIVGtARPDE |
| P12814 | Y859 | Sugiyama | ACTN1 | DKNyITMDELRRELPPDQAEyCIARMAPYTGPDSVPGALDY |
| P13073 | Y38 | Sugiyama | COX4I1 COX4 | SVCVRAHESVVKsEDFsLPAyMDRRDHPLPEVAHVKHLSAS |
| P13639 | Y443 | Sugiyama | EEF2 EF2 | TGLKVRIMGPNytPGKKEDLyLKPIQRTILMMGRYVEPIED |
| P13639 | Y634 | Sugiyama | EEF2 EF2 | AEDIDKGEVsARQELKQRARyLAEKyEWDVAEARKIWCFGP |
| P13639 | Y639 | Sugiyama | EEF2 EF2 | KGEVsARQELKQRARyLAEKyEWDVAEARKIWCFGPDGTGP |
| P13639 | Y671 | Sugiyama | EEF2 EF2 | CFGPDGTGPNILTDITKGVQyLNEIKDSVVAGFQWATKEGA |
| P13667 | Y273 | Sugiyama | PDIA4 ERP70 ERP72 | PTLKIFRKGRPYDYNGPREKyGIVDyMIEQSGPPSKEILTL |
| P13667 | Y278 | Sugiyama | PDIA4 ERP70 ERP72 | FRKGRPYDYNGPREKyGIVDyMIEQSGPPSKEILTLKQVQE |
| P13667 | Y392 | Sugiyama | PDIA4 ERP70 ERP72 | HMMDVQGstQDsAIKDFVLKyALPLVGHRKVSNDAKRYTRR |
| P13667 | Y448 | Sugiyama | PDIA4 ERP70 ERP72 | RAATQFWRSKVLEVAKDFPEytFAIADEEDyAGEVKDLGLs |
| P13667 | Y458 | Sugiyama | PDIA4 ERP70 ERP72 | VLEVAKDFPEytFAIADEEDyAGEVKDLGLsEsGEDVNAAI |
| P13674 | Y141 | Sugiyama | P4HA1 P4HA | FPNDEDQVGAAKALLRLQDtyNLDTDtIsKGNLPGVKHKSF |
| P13674 | Y282 | Sugiyama | P4HA1 P4HA | ASDDQSDQKTTPKKKGVAVDyLPERQKyEMLCRGEGIKMTP |
| P13798 | Y17 | Sugiyama | APEH D3F15S2 D3S48E DNF15S2 | ____MERQVLLsEPEEAAALyRGLSRQPALsAACLGPEVtT |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P13987 | Y86 | Sugiyama | CD59 MIC11 MIN1 MIN2 MIN3 MSK21 | KFEHCNFNDVtTRLRENELtyyCCKKDLCNFNEQLENGGTS |
| P13987 | Y87 | Sugiyama | CD59 MIC11 MIN1 MIN2 MIN3 MSK21 | FEHCNFNDVtTRLRENELtyyCCKKDLCNFNEQLENGGTSL |
| P14324 | Y349 | Sugiyama | FDPS FPS KIAA1293 | QDNKCSWLVVQCLQRATPEQyQILKENYGQKEAEKVARVKA |
| P14625 | Y401 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | VTFKSILFVPTSAPRGLFDEyGsKKSDYIKLYVRRVFITDD |
| P14625 | Y527 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | AKLLRFQssHHPtDItsLDQyVERMKEKQDKIyFMAGsSRK |
| P14625 | Y539 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | tDItsLDQyVERMKEKQDKIyFMAGsSRKEAEssPFVERLL |
| P14649 | Y86 | Sugiyama | MYL6B MLC1SA | LEEFKEAFELFDRVGDGKILysQCGDVMRALGQNPtNAEVL |
| P14854 | Y57 | Sugiyama | COX6B1 COX6B | FHRCQKAMTAKGGDIsVCEWyQRVYQsLCPtsWVTDWDEQR |
| P14927 | Y90 | Sugiyama | UQCRB UQBP | NLKHQILPKEQWTKyEEENFyLEPyLKEVIRERKEREEWAK |
| P15259 | Y92 | Sugiyama | PGAM2 PGAMM | DGTDQMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEEQV |
| P15311 | Y424 | Sugiyama | EZR VIL2 | ERQAVDQIKsQEQLAAELAEytAKIALLEEARRRKEDEVEE |
| P15328 | Y80 | Sugiyama | FOLR1 FOLR | WRKNACCSTNTSQEAHKDVsyLyRFNWNHCGEMAPACKRHF |
| P15880 | Y248 | Sugiyama | RPS2 RPS4 | GCtAtLGNFAKATFDAISKTysyLtPDLWKEtVFtKsPyQE |
| P15880 | Y250 | Sugiyama | RPS2 RPS4 | tAtLGNFAKATFDAISKTysyLtPDLWKEtVFtKsPyQEFt |
| P17066 | Y43 | Sugiyama | HSPA6 HSP70B' | FQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAAL |
| P17931 | Y221 | Sugiyama | LGALS3 MAC2 | QVLVEPDHFKVAVNDAHLLQyNHRVKKLNEISKLGISGDID |
| P17980 | Y185 | Sugiyama | PSMC3 TBP1 | PtEyDsRVKAMEVDERPtEQysDIGGLDKQIQELVEAIVLP |
| P17980 | Y381 | Sugiyama | PSMC3 TBP1 | ARARIMQIHSRKMNVsPDVNyEELARCTDDFNGAQCKAVCV |
| P18124 | Y155 | Sugiyama | RPL7 | IVEPYIAWGYPNLKsVNELIyKRGYGKINKKRIALtDNALI |
| P18206 | Y822 | Sugiyama | VCL | KAVAGNIsDPGLQKsFLDsGyRILGAVAKVREAFQPQEPDF |
| P18615 | Y133 | Sugiyama | NELFE RD RDBP | sIsADDDLQEsSRRPQRKsLyEsFVsssDRLRELGPDGEEA |
| P18615 | Y170 | Sugiyama | NELFE RD RDBP | GEEAEGPGAGDGPPRsFDWGyEERSGAHSsAsPPRsRSRDR |
| P18615 | Y372 | Sugiyama | NELFE RD RDBP | NsPKGCHRDKRTQIVysDDVyKENLVDGF____________ |
| P18621 | S5 | Sugiyama | RPL17 | ________________MVRysLDPENPtKsCKSRGSNLRVH |
| P18621 | Y4 | Sugiyama | RPL17 | _________________MVRysLDPENPtKsCKSRGSNLRV |
| P18669 | S137 | Sugiyama | PGAM1 PGAMA CDABP0006 | RsyDVPPPPMEPDHPFysNIsKDRRyADLtEDQLPsCEsLK |
| P18669 | Y142 | Sugiyama | PGAM1 PGAMA CDABP0006 | PPPPMEPDHPFysNIsKDRRyADLtEDQLPsCEsLKDtIAR |
| P18669 | Y92 | Sugiyama | PGAM1 PGAMA CDABP0006 | DAIDQMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEAQV |
| P19105 | Y155 | Sugiyama | MYL12A MLCB MRLC3 RLC | DEEVDELyREAPIDKKGNFNyIEFtRILKHGAKDKDD____ |
| P20042 | Y176 | Sugiyama | EIF2S2 EIF2B | GIsFsNQtGPAWAGSERDytyEELLNRVFNIMREKNPDMVA |
| P20618 | Y150 | Sugiyama | PSMB1 PSC5 | FPYYVYNIIGGLDEEGKGAVysFDPVGsyQRDsFKAGGSAS |
| P20618 | Y158 | Sugiyama | PSMB1 PSC5 | IGGLDEEGKGAVysFDPVGsyQRDsFKAGGSASAMLQPLLD |
| P20810 | Y339 | Sugiyama | CAST | KAKEEKLEKCGEDDEtIPsEyRLKPATDKDGKPLLPEPEEK |
| P21980 | Y369 | Sugiyama | TGM2 | PGYEGWQALDPTPQEKsEGtyCCGPVPVRAIKEGDLstKyD |
| P22087 | Y118 | Sugiyama | FBL FIB1 FLRN | ICRGKEDALVTKNLVPGEsVyGEKRVsIsEGDDKIEyRAWN |
| P22234 | Y22 | Sugiyama | PAICS ADE2 AIRC PAIS | AtAEVLNIGKKLYEGKtKEVyELLDsPGKVLLQsKDQItAG |
| P22314 | Y451 | Sugiyama | UBA1 A1S9T UBE1 | CLPEDKEVLTEDKCLQRQNRyDGQVAVFGsDLQEKLGKQKY |
| P22314 | Y55 | Sugiyama | UBA1 A1S9T UBE1 | SVPTNGMAKNGsEADIDEGLysRQLyVLGHEAMKRLQTSSV |
| P22392 | Y151 | Sugiyama | NME2 NM23B | SLWFKPEELVDyKSCAHDWVyE___________________ |
| P23193 | Y126 | Sugiyama | TCEA1 GTF2S TFIIS | EsTSsGNVsNRKDETNARDTyVsSFPRAPstsDsVRLKCRE |
| P23246 | Y488 | Sugiyama | SFPQ PSF | PMYQKEREtPPRFAQHGtFEyEysQRWKsLDEMEKQQREQV |
| P23246 | Y490 | Sugiyama | SFPQ PSF | YQKEREtPPRFAQHGtFEyEysQRWKsLDEMEKQQREQVEK |
| P23284 | Y47 | Sugiyama | PPIB CYPB | LPGPSAADEKKKGPKVTVKVyFDLRIGDEDVGRVIFGLFGK |
| P23396 | S35 | Sugiyama | RPS3 OK/SW-cl.26 | GIFKAELNEFLtRELAEDGysGVEVRVtPTRTEIIILATRT |
| P23396 | Y34 | Sugiyama | RPS3 OK/SW-cl.26 | DGIFKAELNEFLtRELAEDGysGVEVRVtPTRTEIIILATR |
| P23434 | Y139 | Sugiyama | GCSH | EVTEINEALAENPGLVNKSCyEDGWLIKMtLsNPsELDELM |
| P23434 | Y164 | Sugiyama | GCSH | LIKMtLsNPsELDELMsEEAyEKYIKSIEE___________ |
| P23527 | Y41 | Sugiyama | H2BC17 H2BFH H2BFN HIST1H2BO | KAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISSKAMG |
| P23527 | Y43 | Sugiyama | H2BC17 H2BFH H2BFN HIST1H2BO | QKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISSKAMGIM |
| P23528 | T70 | Sugiyama | CFL1 CFL | EEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyALyDAtyE |
| P23528 | Y140 | Sugiyama | CFL1 CFL | SKDAIKKKLtGIKHELQANCyEEVKDRCTLAEKLGGsAVIs |
| P23528 | Y68 | Sugiyama | CFL1 CFL | ILEEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyALyDAt |
| P23528 | Y82 | Sugiyama | CFL1 CFL | QtVDDPyAtFVKMLPDKDCRyALyDAtyEtKESKKEDLVFI |
| P23528 | Y85 | Sugiyama | CFL1 CFL | DDPyAtFVKMLPDKDCRyALyDAtyEtKESKKEDLVFIFWA |
| P23528 | Y89 | Sugiyama | CFL1 CFL | AtFVKMLPDKDCRyALyDAtyEtKESKKEDLVFIFWAPESA |
| P23588 | Y211 | Sugiyama | EIF4B | DsDKtDTDWRARPAtDsFDDyPPRRGDDsFGDKYRDRYDsD |
| P23588 | Y593 | Sugiyama | EIF4B | APEPKKPEENPASKFssASKyAALsVDGEDENEGEDyAE__ |
| P24752 | Y214 | Sugiyama | ACAT1 ACAT MAT | GsCAENTAKKLNIARNEQDAyAINsytRSKAAWEAGKFGNE |
| P24752 | Y90 | Sugiyama | ACAT1 ACAT MAT | IAIQGAIEKAGIPKEEVKEAyMGNVLQGGEGQAPTRQAVLG |
| P25205 | Y19 | Sugiyama | MCM3 | __MAGtVVLDDVELREAQRDyLDFLDDEEDQGIyQsKVREL |
| P25205 | Y32 | Sugiyama | MCM3 | LREAQRDyLDFLDDEEDQGIyQsKVRELIsDNQyRLIVNVN |
| P25208 | Y58 | Sugiyama | NFYB HAP3 | SMNDHEDTNGSKESFREQDIyLPIANVARIMKNAIPQTGKI |
| P25398 | Y127 | Sugiyama | RPS12 | sCVVVKDYGKESQAKDVIEEyFKCKK_______________ |
| P25685 | Y5 | Sugiyama | DNAJB1 DNAJ1 HDJ1 HSPF1 | ________________MGKDyyQTLGLARGAsDEEIKRAYR |
| P25685 | Y52 | Sugiyama | DNAJB1 DNAJ1 HDJ1 HSPF1 | HPDKNKEPGAEEKFKEIAEAyDVLSDPRKREIFDRYGEEGL |
| P25685 | Y6 | Sugiyama | DNAJB1 DNAJ1 HDJ1 HSPF1 | _______________MGKDyyQTLGLARGAsDEEIKRAYRR |
| P25786 | Y6 | Sugiyama | PSMA1 HC2 NU PROS30 PSC2 | _______________MFRNQyDNDVtVWsPQGRIHQIEYAM |
| P26196 | Y469 | Sugiyama | DDX6 HLR2 RCK | IEEQLGTEIKPIPsNIDKSLyVAEyHsEPVEDEKP______ |
| P26196 | Y473 | Sugiyama | DDX6 HLR2 RCK | LGTEIKPIPsNIDKSLyVAEyHsEPVEDEKP__________ |
| P27348 | S45 | Sugiyama | YWHAQ | CMKAVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSI |
| P27348 | Y149 | Sugiyama | YWHAQ | LAEVACGDDRKQtIDNsQGAyQEAFDIsKKEMQPTHPIRLG |
| P27348 | Y48 | Sugiyama | YWHAQ | AVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSIEQK |
| P27540 | Y561 | Sugiyama | ARNT BHLHE2 | PLEKSDGLFAQDRDPRFsEIyHNINADQSKGISSSTVPATQ |
| P27695 | Y128 | Sugiyama | APEX1 APE APE1 APEX APX HAP1 REF1 | LQELPGLSHQYWSAPsDKEGysGVGLLsRQCPLKVsyGIGD |
| P27797 | Y109 | Sugiyama | CALR CRTC | QTLVVQFTVKHEQNIDCGGGyVKLFPNSLDQTDMHGDSEYN |
| P27816 | Y47 | Sugiyama | MAP4 | AtLEAEAFDDVVGETVGKTDyIPLLDVDEKtGNsESKKKPC |
| P27824 | Y70 | Sugiyama | CANX | TAPPSSPKVTYKAPVPtGEVyFADsFDRGTLSGWILSKAKK |
| P29353 | Y427 | Sugiyama | SHC1 SHC SHCA | RKQMPPPPPCPGRELFDDPsyVNVQNLDKARQAVGGAGPPN |
| P29401 | Y202 | Sugiyama | TKT | LDINRLGQsDPAPLQHQMDIyQKRCEAFGWHAIIVDGHSVE |
| P29692 | Y26 | Sugiyama | EEF1D EF1D | LAHEKIWFDKFKYDDAERRFyEQMNGPVAGAsRQENGAsVI |
| P30043 | T199 | Sugiyama | BLVRB FLR SCAN | HDLGHFMLRCLttDEyDGHstyPsHQyQ_____________ |
| P30043 | Y200 | Sugiyama | BLVRB FLR SCAN | DLGHFMLRCLttDEyDGHstyPsHQyQ______________ |
| P30043 | Y205 | Sugiyama | BLVRB FLR SCAN | MLRCLttDEyDGHstyPsHQyQ___________________ |
| P30086 | Y106 | Sugiyama | PEBP1 PBP PEBP | HFLVVNMKGNDIssGtVLsDyVGsGPPKGtGLHRyVWLVyE |
| P30086 | Y120 | Sugiyama | PEBP1 PBP PEBP | GtVLsDyVGsGPPKGtGLHRyVWLVyEQDRPLKCDEPILsN |
| P30086 | Y125 | Sugiyama | PEBP1 PBP PEBP | DyVGsGPPKGtGLHRyVWLVyEQDRPLKCDEPILsNRsGDH |
| P30086 | Y169 | Sugiyama | PEBP1 PBP PEBP | FKVAsFRKKyELRAPVAGtCyQAEWDDyVPKLyEQLsGK__ |
| P30086 | Y176 | Sugiyama | PEBP1 PBP PEBP | KKyELRAPVAGtCyQAEWDDyVPKLyEQLsGK_________ |
| P30086 | Y64 | Sugiyama | PEBP1 PBP PEBP | tQVKNRPtsIsWDGLDsGKLytLVLtDPDAPsRKDPKYREW |
| P30101 | Y100 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | LAKVDCTANTNTCNKyGVsGyPtLKIFRDGEEAGAyDGPRt |
| P30101 | Y115 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | yGVsGyPtLKIFRDGEEAGAyDGPRtADGIVsHLKKQAGPA |
| P30101 | Y445 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | KDPNIVIAKMDAtANDVPsPyEVRGFPtIyFsPANKKLNPK |
| P30101 | Y67 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | LMLVEFFAPWCGHCKRLAPEyEAAAtRLKGIVPLAKVDCTA |
| P30101 | Y95 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | KGIVPLAKVDCTANTNTCNKyGVsGyPtLKIFRDGEEAGAy |
| P30622 | Y108 | Sugiyama | CLIP1 CYLN1 RSN | AGIVLDEPIGKNDGSVAGVRyFQCEPLKGIFTRPSKLTRKV |
| P31327 | Y1450 | Sugiyama | CPS1 | GsIDLVINLPNNNTKFVHDNyVIRRTAVDSGIPLLTNFQVT |
| P31943 | Y266 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | yNGYNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGstFQst |
| P31946 | S47 | Sugiyama | YWHAB | AMKAVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P31946 | Y106 | Sugiyama | YWHAB | EKIEAELQDICNDVLELLDKyLIPNATQPESKVFyLKMKGD |
| P31946 | Y21 | Sugiyama | YWHAB | MTMDKsELVQKAKLAEQAERyDDMAAAMKAVtEQGHELsNE |
| P31946 | Y213 | Sugiyama | YWHAB | LAKTAFDEAIAELDtLNEEsyKDstLIMQLLRDNLtLWtSE |
| P31946 | Y50 | Sugiyama | YWHAB | AVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSIEQK |
| P31947 | S45 | Sugiyama | SFN HME1 | FMKGAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsI |
| P31947 | Y151 | Sugiyama | SFN HME1 | LAEVATGDDKKRIIDSARsAyQEAMDISKKEMPPTNPIRLG |
| P31947 | Y48 | Sugiyama | SFN HME1 | GAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsIEQK |
| P31948 | Y354 | Sugiyama | STIP1 | DVLKKCQQAEKILKEQERLAyINPDLALEEKNKGNECFQKG |
| P32119 | Y115 | Sugiyama | PRDX2 NKEFB TDPX1 | GLGPLNIPLLADVTRRLsEDyGVLKTDEGIAYRGLFIIDGK |
| P32969 | Y180 | Sugiyama | RPL9 OK/SW-cl.103; RPL9P7; RPL9P8; RPL9P9 | LIQQATTVKNKDIRKFLDGIyVsEKGtVQQADE________ |
| P33121 | T695 | Sugiyama | ACSL1 FACL1 FACL2 LACS LACS1 LACS2 | KAKRPELRNYFRSQIDDLyStIKV_________________ |
| P33121 | Y693 | Sugiyama | ACSL1 FACL1 FACL2 LACS LACS1 LACS2 | TMKAKRPELRNYFRSQIDDLyStIKV_______________ |
| P33176 | Y62 | Sugiyama | KIF5B KNS KNS1 | ASKPYAFDRVFQSsTsQEQVyNDCAKKIVKDVLEGyNGtIF |
| P33316 | Y167 | Sugiyama | DUT | PPMEKAVVKTDIQIALPsGCyGRVAPRSGLAAKHFIDVGAG |
| P33778 | Y41 | Sugiyama | H2BC3 H2BFF HIST1H2BB | KAQKKDGKKRKRsRKEsysIyVyKVLKQVHPDTGISSKAMG |
| P33778 | Y43 | Sugiyama | H2BC3 H2BFF HIST1H2BB | QKKDGKKRKRsRKEsysIyVyKVLKQVHPDTGISSKAMGIM |
| P33993 | Y333 | Sugiyama | MCM7 CDC47 MCM2 | EsGAGELtREELRQIAEEDFyEKLAASIAPEIYGHEDVKKA |
| P33993 | Y393 | Sugiyama | MCM7 CDC47 MCM2 | GNINICLMGDPGVAKSQLLsyIDRLAPRSQYTTGRGssGVG |
| P34897 | Y105 | Sugiyama | SHMT2 | LEALGsCLNNKYSEGYPGKRyyGGAEVVDEIELLCQRRALE |
| P34897 | Y106 | Sugiyama | SHMT2 | EALGsCLNNKYSEGYPGKRyyGGAEVVDEIELLCQRRALEA |
| P34931 | Y43 | Sugiyama | HSPA1L | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P34932 | Y30 | Sugiyama | HSPA4 APG2 HSPH2 | FQSCYVAVARAGGIETIANEysDRCtPACIsFGPKNRSIGA |
| P34932 | Y597 | Sugiyama | HSPA4 APG2 HSPH2 | VDLPIENQLLWQIDREMLNLyIENEGKMIMQDKLEKERNDA |
| P34932 | Y624 | Sugiyama | HSPA4 APG2 HSPH2 | MIMQDKLEKERNDAKNAVEEyVyEMRDKLSGEYEKFVSEDD |
| P34932 | Y626 | Sugiyama | HSPA4 APG2 HSPH2 | MQDKLEKERNDAKNAVEEyVyEMRDKLSGEYEKFVSEDDRN |
| P35221 | Y177 | Sugiyama | CTNNA1 | VEDGILKLRNAGNEQDLGIQyKALKPEVDKLNIMAAKRQQE |
| P35268 | Y114 | Sugiyama | RPL22 | NNLRDWLRVVANSKESYELRyFQINQDEEEEEDED______ |
| P35580 | Y13 | Sugiyama | MYH10 | ________MAQRTGLEDPERyLFVDRAVIYNPATQADWTAK |
| P35637 | Y468 | Sugiyama | FUS TLS | KAPKPDGPGGGPGGsHMGGNyGDDRRGGRGGYDRGGYRGRG |
| P36954 | Y54 | Sugiyama | POLR2I | ILLyACRNCDYQQEADNSCIyVNKITHEVDELtQIIADVsQ |
| P37108 | Y27 | Sugiyama | SRP14 | EQFLtELTRLFQKCRTSGsVyItLKKYDGRTKPIPKKGtVE |
| P37802 | Y192 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NVIGLQMGtNRGAsQAGMtGyGMPRQIL_____________ |
| P38646 | Y118 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | ERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIK |
| P38646 | Y196 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | EtAENyLGHtAKNAVItVPAyFNDsQRQAtKDAGQIsGLNV |
| P38646 | Y652 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | NIRQAAssLQQASLKLFEMAyKKMAsEREGSGsSGTGEQKE |
| P39019 | Y48 | Sugiyama | RPS19 | LKVPEWVDtVKLAKHKELAPyDENWFytRAAstARHLYLRG |
| P39019 | Y54 | Sugiyama | RPS19 | VDtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGs |
| P40261 | Y11 | Sugiyama | NNMT | __________MESGFTSKDTyLSHFNPRDYLEKYYKFGSRH |
| P40429 | Y149 | Sugiyama | RPL13A | LKPTRKFAYLGRLAHEVGWKyQAVtAtLEEKRKEKAKIHYR |
| P40926 | Y80 | Sugiyama | MDH2 | HtPGVAADLsHIEtKAAVKGyLGPEQLPDCLKGCDVVVIPA |
| P40939 | Y637 | Sugiyama | HADHA HADH | ELLTQMVSKGFLGRKSGKGFyIyQEGVKRKDLNSDMDSILA |
| P40939 | Y639 | Sugiyama | HADHA HADH | LTQMVSKGFLGRKSGKGFyIyQEGVKRKDLNSDMDSILASL |
| P41219 | Y287 | Sugiyama | PRPH NEF4 PRPH1 | DIRAQYESIAAKNLQEAEEWyKSKYADLSDAANRNHEALRQ |
| P41227 | Y145 | Sugiyama | NAA10 ARD1 ARD1A TE2 | TLNFQISEVEPKyyADGEDAyAMKRDLtQMADELRRHLELK |
| P41236 | Y148 | Sugiyama | PPP1R2 IPP2 | DLsPEEREKKRQFEMKRKLHyNEGLNIKLARQLISKDLHDD |
| P41567 | Y30 | Sugiyama | EIF1 SUI1 | FDPFADAsKGDDLLPAGTEDyIHIRIQQRNGRKtLttVQGI |
| P42025 | Y33 | Sugiyama | ACTR1B CTRN2 | VIDNGSGVIKAGFAGDQIPKyCFPNyVGRPKHMRVMAGALE |
| P42025 | Y38 | Sugiyama | ACTR1B CTRN2 | SGVIKAGFAGDQIPKyCFPNyVGRPKHMRVMAGALEGDLFI |
| P42224 | Y170 | Sugiyama | STAT1 | KDKVMCIEHEIKsLEDLQDEyDFKCKTLQNREHETNGVAKS |
| P43034 | Y28 | Sugiyama | PAFAH1B1 LIS1 MDCR MDS PAFAHA | RDELNRAIADyLRSNGyEEAySVFKKEAELDVNEELDKKYA |
| P43243 | S211 | Sugiyama | MATR3 KIAA0723 | DRGPsLNPVLDyDHGsRsQEsGyyDRMDyEDDRLRDGERCR |
| P43243 | Y213 | Sugiyama | MATR3 KIAA0723 | GPsLNPVLDyDHGsRsQEsGyyDRMDyEDDRLRDGERCRDD |
| P43243 | Y214 | Sugiyama | MATR3 KIAA0723 | PsLNPVLDyDHGsRsQEsGyyDRMDyEDDRLRDGERCRDDs |
| P43243 | Y243 | Sugiyama | MATR3 KIAA0723 | RLRDGERCRDDsFFGEtsHNyHKFDsEyERMGRGPGPLQER |
| P46777 | Y207 | Sugiyama | RPL5 MSTP030 | sKEFNAEVHRKHIMGQNVADyMRyLMEEDEDAyKKQFsQyI |
| P46777 | Y210 | Sugiyama | RPL5 MSTP030 | FNAEVHRKHIMGQNVADyMRyLMEEDEDAyKKQFsQyIKNs |
| P46777 | Y219 | Sugiyama | RPL5 MSTP030 | IMGQNVADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEM |
| P46777 | Y240 | Sugiyama | RPL5 MSTP030 | KKQFsQyIKNsVtPDMMEEMyKKAHAAIRENPVyEKKPKKE |
| P46778 | Y156 | Sugiyama | RPL21 | REAHFVRTNGKEPELLEPIPyEFMA________________ |
| P46778 | Y30 | Sugiyama | RPL21 | GTRYMFSRPFRKHGVVPLAtyMRIYKKGDIVDIKGMGTVQK |
| P46937 | Y407 | Sugiyama | YAP1 YAP65 | NsGtyHsRDEstDsGLsMssysVPRtPDDFLNsVDEMDTGD |
| P46940 | Y1478 | Sugiyama | IQGAP1 KIAA0051 | KIQTGLKKLTELGtVDPKNKyQELINDIARDIRNQRRYRQR |
| P46940 | Y385 | Sugiyama | IQGAP1 KIAA0051 | PLQKEELQsGVDAANSAAQQyQRRLAAVALINAAIQKGVAE |
| P46940 | Y41 | Sugiyama | IQGAP1 KIAA0051 | LDNERLTAEEMDERRRQNVAyEyLCHLEEAKRWMEACLGED |
| P46940 | Y43 | Sugiyama | IQGAP1 KIAA0051 | NERLTAEEMDERRRQNVAyEyLCHLEEAKRWMEACLGEDLP |
| P47756 | Y232 | Sugiyama | CAPZB | NIGRLVEDMENKIRstLNEIyFGKTKDIVNGLRSVQTFADK |
| P47756 | Y59 | Sugiyama | CAPZB | LLSSVDQPLKIARDKVVGKDyLLCDyNRDGDSyRsPWSNKy |
| P47914 | Y98 | Sugiyama | RPL29 | PKEVKPKIPKGVSRKLDRLAyIAHPKLGKRARARIAKGLRL |
| P48643 | S270 | Sugiyama | CCT5 CCTE KIAA0098 | ILTCPFEPPKPKTKHKLDVtsVEDyKALQKYEKEKFEEMIQ |
| P48643 | Y274 | Sugiyama | CCT5 CCTE KIAA0098 | PFEPPKPKTKHKLDVtsVEDyKALQKYEKEKFEEMIQQIKE |
| P48741 | Y43 | Sugiyama | HSPA7 HSP70B | FQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAAL |
| P49207 | Y32 | Sugiyama | RPL34 | sYNtASNKTRLSRTPGNRIVyLytKKVGKAPKSACGVCPGR |
| P49207 | Y34 | Sugiyama | RPL34 | NtASNKTRLSRTPGNRIVyLytKKVGKAPKSACGVCPGRLR |
| P49327 | Y45 | Sugiyama | FASN FAS | NLIGGVDMVTDDDRRWKAGLyGLPRRsGKLKDLSRFDAsFF |
| P49588 | Y192 | Sugiyama | AARS1 AARS | KDNFWEMGDtGPCGPCsEIHyDRIGGRDAAHLVNQDDPNVL |
| P50502 | Y185 | Sugiyama | ST13 AAG2 FAM10A1 HIP SNC6 | NAAIRDCDRAIEINPDsAQPyKWRGKAHRLLGHWEEAAHDL |
| P50897 | Y264 | Sugiyama | PPT1 CLN1 PPT | FGFYRsGQAKEtIPLQEtsLytQDRLGLKEMDNAGQLVFLA |
| P50990 | T424 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | RDKRLVPGGGAtEIELAKQItsyGETCPGLEQyAIKKFAEA |
| P50990 | Y30 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | GFAQMLKEGAKHFsGLEEAVyRNIQACKELAQTTRTAYGPN |
| P50990 | Y436 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | EIELAKQItsyGETCPGLEQyAIKKFAEAFEAIPRALAENS |
| P50995 | Y482 | Sugiyama | ANXA11 ANX11 | sEtDLLDIRSEYKRMYGKsLyHDISGDtsGDyRKILLKICG |
| P50995 | Y493 | Sugiyama | ANXA11 ANX11 | YKRMYGKsLyHDISGDtsGDyRKILLKICGGND________ |
| P51116 | Y614 | Sugiyama | FXR2 FMR1L2 | RGNRtDGsIsGDRQPVtVADyIsRAEsQsRQRPPLERTKPs |
| P51965 | Y77 | Sugiyama | UBE2E1 UBCH6 | ADITLDPPPNCSAGPKGDNIyEWRSTILGPPGSVYEGGVFF |
| P52272 | Y681 | Sugiyama | HNRNPM HNRPM NAGR1 | PFDFTWKMLKDKFNECGHVLyADIKMENGKSKGCGVVKFEs |
| P52565 | Y156 | Sugiyama | ARHGDIA GDIA1 | GVKIDKtDyMVGsYGPRAEEyEFLtPVEEAPKGMLARGsYs |
| P52597 | Y266 | Sugiyama | HNRNPF HNRPF | ySGLSDGYGFTTDLFGRDLsyCLsGMyDHRYGDsEFtVQsT |
| P52597 | Y82 | Sugiyama | HNRNPF HNRPF | GsEDDVKMALKKDRESMGHRyIEVFKSHRTEMDWVLKHsGP |
| P52888 | Y576 | Sugiyama | THOP1 | VLAKVDQALHTQTDADPAEEyARLCQEILGVPATPGTNMPA |
| P52948 | Y208 | Sugiyama | NUP98 ADAR2 | CITAMKEYESKSLEELRLEDyQANRKGPQNQVGAGTTTGLF |
| P52948 | Y741 | Sugiyama | NUP98 ADAR2 | EIENNsYHMHPAGIILtKVGyytIPsMDDLAKITNEKGECI |
| P52948 | Y742 | Sugiyama | NUP98 ADAR2 | IENNsYHMHPAGIILtKVGyytIPsMDDLAKITNEKGECIV |
| P52948 | Y848 | Sugiyama | NUP98 ADAR2 | PTDKTSRCLIKsPDRLADINyEGRLEAVSRKQGAQFKEyRP |
| P53634 | Y438 | Sugiyama | CTSC CPPI | SGMDYWIVKNsWGtGWGENGyFRIRRGtDECAIEsIAVAAt |
| P54105 | Y38 | Sugiyama | CLNS1A CLCI ICLN | RQQPDTEAVLNGKGLGtGtLyIAEsRLSWLDGsGLGFSLEY |
| P54577 | Y388 | Sugiyama | YARS1 YARS | LDIRVGKIITVEKHPDADsLyVEKIDVGEAEPRTVVSGLVQ |
| P54652 | Y42 | Sugiyama | HSPA2 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P55060 | Y369 | Sugiyama | CSE1L CAS XPO2 | VPNMEFRAADEEAFEDNsEEyIRRDLEGsDIDTRRRAACDL |
| P55196 | Y1230 | Sugiyama | AFDN AF6 MLLT4 | QtPPPRPEAyPIPtQtYtREyFtFPAsKsQDRMAPPQNQWP |
| P55209 | Y106 | Sugiyama | NAP1L1 NRP | VKCAQIEAKFyEEVHDLERKyAVLyQPLFDKRFEIINAIYE |
| P55209 | Y110 | Sugiyama | NAP1L1 NRP | QIEAKFyEEVHDLERKyAVLyQPLFDKRFEIINAIYEPTEE |
| P55209 | Y96 | Sugiyama | NAP1L1 NRP | RRVNALKNLQVKCAQIEAKFyEEVHDLERKyAVLyQPLFDK |
| P55327 | Y136 | Sugiyama | TPD52 | LQELKQNIAKGWQDVTATSAyKKTSETLSQAGQKASAAFSS |
| P55795 | Y266 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | YGGYNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGssFQst |
| P56270 | Y307 | Sugiyama | MAZ ZNF801 | AFRDVYHLNRHKLSHsDEKPyQCPVCQQRFKRKDRMSYHVR |
| P57053 | Y41 | Sugiyama | H2BC12L H2BFS H2BS1 | KAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| P57053 | Y43 | Sugiyama | H2BC12L H2BFS H2BS1 | QKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| P58876 | Y41 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| P58876 | Y43 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| P60174 | Y209 | Sugiyama | TPI1 TPI | LRGWLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDG |
| P60228 | Y445 | Sugiyama | EIF3E EIF3S6 INT6 | KLNQNSRSEAPNWAtQDsGFy____________________ |
| P60660 | Y29 | Sugiyama | MYL6 | TAEFKEAFQLFDRtGDGKILysQCGDVMRALGQNPtNAEVL |
| P60660 | Y86 | Sugiyama | MYL6 | DFEHFLPMLQTVAKNKDQGtyEDyVEGLRVFDKEGNGtVMG |
| P60660 | Y89 | Sugiyama | MYL6 | HFLPMLQTVAKNKDQGtyEDyVEGLRVFDKEGNGtVMGAEI |
| P60709 | Y188 | Sugiyama | ACTB | GyALPHAILRLDLAGRDLTDyLMKILtERGysFtttAEREI |
| P60709 | Y198 | Sugiyama | ACTB | LDLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCy |
| P60709 | Y240 | Sugiyama | ACTB | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P60709 | Y362 | Sugiyama | ACTB | GGsILAsLstFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P60842 | Y70 | Sugiyama | EIF4A1 DDX2A EIF4A | yGFEKPsAIQQRAILPCIKGyDVIAQAQsGtGKTATFAISI |
| P61024 | Y7 | Sugiyama | CKS1B CKS1 PNAS-143 PNAS-16 | ______________MSHKQIyysDKyDDEEFEyRHVMLPKD |
| P61024 | Y8 | Sugiyama | CKS1B CKS1 PNAS-143 PNAS-16 | _____________MSHKQIyysDKyDDEEFEyRHVMLPKDI |
| P61081 | Y172 | Sugiyama | UBE2M UBC12 | VLQNNRRLFEQNVQRSMRGGyIGstyFERCLK_________ |
| P61081 | Y177 | Sugiyama | UBE2M UBC12 | RRLFEQNVQRSMRGGyIGstyFERCLK______________ |
| P61163 | Y241 | Sugiyama | ACTR1A CTRN1 | ACYLSINPQKDETLETEKAQyyLPDGstIEIGPSRFRAPEL |
| P61163 | Y242 | Sugiyama | ACTR1A CTRN1 | CYLSINPQKDETLETEKAQyyLPDGstIEIGPSRFRAPELL |
| P61163 | Y33 | Sugiyama | ACTR1A CTRN1 | VIDNGSGVIKAGFAGDQIPKyCFPNyVGRPKHVRVMAGALE |
| P61163 | Y38 | Sugiyama | ACTR1A CTRN1 | SGVIKAGFAGDQIPKyCFPNyVGRPKHVRVMAGALEGDIFI |
| P61221 | Y594 | Sugiyama | ABCE1 RLI RNASEL1 RNASELI RNS4I OK/SW-cl.40 | RPRINKLNsIKDVEQKKsGNyFFLDD_______________ |
| P61247 | Y256 | Sugiyama | RPS3A FTE1 MFTL | sssGKAtGDEtGAKVERADGyEPPVQEsV____________ |
| P61313 | Y6 | Sugiyama | RPL15 EC45 TCBAP0781 | _______________MGAYKyIQELWRKKQSDVMRFLLRVR |
| P61353 | Y85 | Sugiyama | RPL27 | RSKIKSFVKVyNyNHLMPtRysVDIPLDKtVVNKDVFRDPA |
| P61604 | Y88 | Sugiyama | HSPE1 | GDKVLLPEyGGtKVVLDDKDyFLFRDGDILGKyVD______ |
| P61978 | Y323 | Sugiyama | HNRNPK HNRPK | RARNLPLPPPPPPRGGDLMAyDRRGRPGDRYDGMVGFSADE |
| P61981 | S215 | Sugiyama | YWHAG | HLAKtAFDDAIAELDtLNEDsyKDstLIMQLLRDNLtLWts |
| P61981 | S46 | Sugiyama | YWHAG | AMKNVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P61981 | Y20 | Sugiyama | YWHAG | _MVDREQLVQKARLAEQAERyDDMAAAMKNVtELNEPLsNE |
| P61981 | Y49 | Sugiyama | YWHAG | NVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSIEQK |
| P62081 | Y177 | Sugiyama | RPS7 | HLDKAQQNNVEHKVEtFsGVyKKLTGKDVNFEFPEFQL___ |
| P62191 | Y184 | Sugiyama | PSMC1 | MDDTDPLVTVMKVEKAPQETyADIGGLDNQIQEIKESVELP |
| P62241 | Y113 | Sugiyama | RPS8 OK/SW-cl.83 | TKTLVKNCIVLIDStPYRQWyEsHyALPLGRKKGAKLtPEE |
| P62241 | Y117 | Sugiyama | RPS8 OK/SW-cl.83 | VKNCIVLIDStPYRQWyEsHyALPLGRKKGAKLtPEEEEIL |
| P62241 | Y198 | Sugiyama | RPS8 OK/SW-cl.83 | RPGQCGRADGyVLEGKELEFyLRKIKARKGK__________ |
| P62258 | S46 | Sugiyama | YWHAE | SMKKVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssI |
| P62258 | Y152 | Sugiyama | YWHAE | LAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHPIRLG |
| P62258 | Y214 | Sugiyama | YWHAE | LAKAAFDDAIAELDtLsEEsyKDstLIMQLLRDNLtLWtsD |
| P62258 | Y49 | Sugiyama | YWHAE | KVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssIEQK |
| P62263 | S70 | Sugiyama | RPS14 PRO2640 | KETICRVTGGMKVKADRDEssPyAAMLAAQDVAQRCKELGI |
| P62269 | Y95 | Sugiyama | RPS18 D6S218E | RQYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLK |
| P62273 | Y7 | Sugiyama | RPS29 | ______________MGHQQLyWsHPRKFGQGSRSCRVCSNR |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62277 | Y18 | Sugiyama | RPS13 | ___MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVKEQIy |
| P62280 | Y55 | Sugiyama | RPS11 | RYYKNIGLGFKtPKEAIEGtyIDKKCPFTGNVsIRGRILsG |
| P62306 | Y71 | Sugiyama | SNRPF PBSCF | IDGALSGHLGEVLIRCNNVLyIRGVEEEEEDGEMRE_____ |
| P62312 | Y72 | Sugiyama | LSM6 | VNGQLKNKyGDAFIRGNNVLyIstQKRRM____________ |
| P62495 | Y345 | Sugiyama | ETF1 ERF1 RF1 SUP45L1 | NLDIMRYVLHCQGTEEEKILyLTPEQEKDKSHFTDKETGQE |
| P62736 | Y190 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | GyALPHAIMRLDLAGRDLTDyLMKILTERGysFVttAEREI |
| P62736 | Y242 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P62750 | Y144 | Sugiyama | RPL23A | VNtLIRPDGEKKAYVRLAPDyDALDVANKIGII________ |
| P62750 | Y74 | Sugiyama | RPL23A | LRRQPKYPRKSAPRRNKLDHyAIIKFPLTTEsAMKKIEDNN |
| P62753 | Y156 | Sugiyama | RPS6 OK/SW-cl.2 | KRASRIRKLFNLsKEDDVRQyVVRKPLNKEGKKPRTKAPKI |
| P62807 | Y41 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | KAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIssKAMG |
| P62807 | Y43 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | QKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| P62826 | Y146 | Sugiyama | RAN ARA24 OK/SW-cl.81 | IKDRKVKAKsIVFHRKKNLQyyDIsAKSNyNFEKPFLWLAR |
| P62826 | Y147 | Sugiyama | RAN ARA24 OK/SW-cl.81 | KDRKVKAKsIVFHRKKNLQyyDIsAKSNyNFEKPFLWLARK |
| P62906 | Y11 | Sugiyama | RPL10A NEDD6 | __________MSSKVsRDtLyEAVREVLHGNQRKRRKFLET |
| P62917 | S130 | Sugiyama | RPL8 | GTIVCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKL |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P62942 | Y27 | Sugiyama | FKBP1A FKBP1 FKBP12 | tIsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRDRNKPF |
| P62979 | Y148 | Sugiyama | RPS27A UBA80 UBCEP1 | AGVFMAsHFDRHyCGKCCLtyCFNKPEDK____________ |
| P63104 | S45 | Sugiyama | YWHAZ | CMKsVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssI |
| P63104 | Y149 | Sugiyama | YWHAZ | LAEVAAGDDKKGIVDQsQQAyQEAFEIsKKEMQPTHPIRLG |
| P63104 | Y211 | Sugiyama | YWHAZ | LAKtAFDEAIAELDtLsEEsyKDstLIMQLLRDNLtLWtsD |
| P63104 | Y48 | Sugiyama | YWHAZ | sVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssIEQK |
| P63173 | Y41 | Sugiyama | RPL38 | KSVKIKKNKDNVKFKVRCSRyLytLVItDKEKAEKLKQSLP |
| P63173 | Y43 | Sugiyama | RPL38 | VKIKKNKDNVKFKVRCSRyLytLVItDKEKAEKLKQSLPPG |
| P63220 | T52 | Sugiyama | RPS21 | IQMNVAEVDKVTGRFNGQFKtyAICGAIRRMGEsDDsILRL |
| P63220 | Y53 | Sugiyama | RPS21 | QMNVAEVDKVTGRFNGQFKtyAICGAIRRMGEsDDsILRLA |
| P63261 | Y188 | Sugiyama | ACTG1 ACTG | GyALPHAILRLDLAGRDLTDyLMKILtERGysFtttAEREI |
| P63261 | Y198 | Sugiyama | ACTG1 ACTG | LDLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCy |
| P63261 | Y240 | Sugiyama | ACTG1 ACTG | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P63261 | Y362 | Sugiyama | ACTG1 ACTG | GGsILAsLstFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P63267 | Y189 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | GyALPHAIMRLDLAGRDLTDyLMKILTERGysFVttAEREI |
| P63267 | Y241 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P67809 | Y197 | Sugiyama | YBX1 NSEP1 YB1 | APEGQAQQRRPyRRRRFPPyyMRRPYGRRPQysNPPVQGEV |
| P67809 | Y208 | Sugiyama | YBX1 NSEP1 YB1 | yRRRRFPPyyMRRPYGRRPQysNPPVQGEVMEGADNQGAGE |
| P68032 | Y190 | Sugiyama | ACTC1 ACTC | GyALPHAIMRLDLAGRDLTDyLMKILTERGysFVttAEREI |
| P68032 | Y242 | Sugiyama | ACTC1 ACTC | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68104 | Y29 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | NIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKFEKEAAEM |
| P68104 | Y85 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | AERERGITIDISLWKFEtsKyyVtIIDAPGHRDFIKNMITG |
| P68133 | Y190 | Sugiyama | ACTA1 ACTA | GyALPHAIMRLDLAGRDLTDyLMKILTERGysFVttAEREI |
| P68133 | Y242 | Sugiyama | ACTA1 ACTA | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68363 | S439 | Sugiyama | TUBA1B | SEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy________ |
| P68363 | T225 | Sugiyama | TUBA1B | DNEAIYDICRRNLDIERPtytNLNRLIsQIVSsITASLRFD |
| P68363 | Y432 | Sugiyama | TUBA1B | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| P68363 | Y451 | Sugiyama | TUBA1B | DyEEVGVDsVEGEGEEEGEEy____________________ |
| P68366 | T225 | Sugiyama | TUBA4A TUBA1 | DNEAIYDICRRNLDIERPtytNLNRLIsQIVSsITASLRFD |
| P78345 | Y29 | Sugiyama | RPP38 | GRGsLRKTRPLVVKTSLNNPyIIRWSALESEDMHFILQTLE |
| P83731 | Y11 | Sugiyama | RPL24 | __________MKVELCsFsGyKIYPGHGRRYARTDGKVFQF |
| P83731 | Y55 | Sugiyama | RPL24 | KCEsAFLSKRNPRQINWtVLyRRKHKKGQsEEIQKKRTRRA |
| P84103 | Y33 | Sugiyama | SRSF3 SFRS3 SRP20 | yVGNLGNNGNKtELERAFGyyGPLRSVWVARNPPGFAFVEF |
| P98082 | Y38 | Sugiyama | DAB2 DOC2 | AAPKAPsKKEKKKGPEKTDEyLLARFKGDGVKYKAKLIGID |
| P98175 | Y694 | Sugiyama | RBM10 DXS8237E GPATC9 GPATCH9 KIAA0122 | QPISSLRDDERREsAtADAGyAILEKKGALAERQHTsMDLP |
| P98179 | Y117 | Sugiyama | RBM3 RNPL | HGRGRSYSRGGGDQGYGSGRyyDsRPGGyGyGyGRSRDYNG |
| P98179 | Y118 | Sugiyama | RBM3 RNPL | GRGRSYSRGGGDQGYGSGRyyDsRPGGyGyGyGRSRDYNGR |
| Q00169 | Y140 | Sugiyama | PITPNA PITPN | GTQENVHKLEPEAWKHVEAVyIDIADRSQVLSKDYKAEEDP |
| Q00610 | Y883 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | EARIHEGCEEPAtHNALAKIyIDsNNNPERFLRENPyyDsR |
| Q00653 | Y247 | Sugiyama | NFKB2 LYT10 | NLKISRMDKTAGSVRGGDEVyLLCDKVQKDDIEVRFYEDDE |
| Q00839 | Y257 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | QKGGDKKRGVKRPREDHGRGyFEyIEENKysRAKsPQPPVE |
| Q00839 | Y260 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | GDKKRGVKRPREDHGRGyFEyIEENKysRAKsPQPPVEEED |
| Q01105 | S133 | Sugiyama | SET | DEEALHYLTRVEVtEFEDIKsGyRIDFyFDENPyFENKVLS |
| Q01105 | Y140 | Sugiyama | SET | LTRVEVtEFEDIKsGyRIDFyFDENPyFENKVLSKEFHLNE |
| Q01105 | Y146 | Sugiyama | SET | tEFEDIKsGyRIDFyFDENPyFENKVLSKEFHLNEsGDPss |
| Q01130 | Y44 | Sugiyama | SRSF2 SFRS2 | RtsPDtLRRVFEKYGRVGDVyIPRDRYTKESRGFAFVRFHD |
| Q02878 | Y216 | Sugiyama | RPL6 TXREB1 | AtsTKIDISNVKIPKHLtDAyFKKKKLRKPRHQEGEIFDtE |
| Q04760 | Y49 | Sugiyama | GLO1 | DFLLQQtMLRVKDPKKSLDFyTRVLGMtLIQKCDFPIMKFS |
| Q04837 | Y73 | Sugiyama | SSBP1 SSBP | PVTIFSLATNEMWRsGDsEVyQLGDVsQKTTWHRISVFRPG |
| Q04917 | S46 | Sugiyama | YWHAH YWHA1 | AMKAVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSI |
| Q04917 | Y154 | Sugiyama | YWHAH YWHA1 | LAEVASGEKKNsVVEAsEAAyKEAFEISKEQMQPTHPIRLG |
| Q04917 | Y49 | Sugiyama | YWHAH YWHA1 | AVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSIEQK |
| Q05639 | Y29 | Sugiyama | EEF1A2 EEF1AL STN | NIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKFEKEAAEM |
| Q06830 | Y116 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | GLGPMNIPLVSDPKRtIAQDyGVLKADEGIsFRGLFIIDDK |
| Q06830 | Y34 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | NFKAtAVMPDGQFKDIsLsDyKGKYVVFFFYPLDFTFVCPT |
| Q07157 | Y1355 | Sugiyama | TJP1 ZO1 | KPPEDIVRSNHyDPEEDEEyyRKQLsyFDRRsFENKPPAHI |
| Q07666 | Y145 | Sugiyama | KHDRBS1 SAM68 | LtAEIEKIQKGDSKKDDEENyLDLFsHKNMKLKERVLIPVK |
| Q07866 | Y449 | Sugiyama | KLC1 KLC KNS2 | HAEEREECKGKQKDGTsFGEyGGWyKACKVDsPtVTTtLKN |
| Q07866 | Y453 | Sugiyama | KLC1 KLC KNS2 | REECKGKQKDGTsFGEyGGWyKACKVDsPtVTTtLKNLGAL |
| Q07955 | Y189 | Sugiyama | SRSF1 ASF SF2 SF2P33 SFRS1 OK/SW-cl.3 | TYAVRKLDNTKFRsHEGEtAyIRVKVDGPRsPsyGRsRsRs |
| Q07955 | Y37 | Sugiyama | SRSF1 ASF SF2 SF2P33 SFRS1 OK/SW-cl.3 | RIyVGNLPPDIRtKDIEDVFyKYGAIRDIDLKNRRGGPPFA |
| Q08043 | Y229 | Sugiyama | ACTN3 | KLRKDDPIGNLNTAFEVAEKyLDIPKMLDAEDIVNtPKPDE |
| Q08211 | Y68 | Sugiyama | DHX9 DDX9 LKP NDH2 | MGNSTNKKDAQSNAARDFVNyLVRINEIKsEEVPAFGVAsP |
| Q08J23 | Y51 | Sugiyama | NSUN2 SAKI TRM4 | EAGWEGGyPEIVKENKLFEHyyQELKIVPEGEWGQFMDALR |
| Q08J23 | Y52 | Sugiyama | NSUN2 SAKI TRM4 | AGWEGGyPEIVKENKLFEHyyQELKIVPEGEWGQFMDALRE |
| Q12931 | Y513 | Sugiyama | TRAP1 HSP75 HSPC5 | GtRNIyyLCAPNRHLAEHsPyyEAMKKKDTEVLFCFEQFDE |
| Q12931 | Y514 | Sugiyama | TRAP1 HSP75 HSPC5 | tRNIyyLCAPNRHLAEHsPyyEAMKKKDTEVLFCFEQFDEL |
| Q12986 | Y1115 | Sugiyama | NFX1 NFX2 | sDKNPGSSNLQKITKEPIIDyFDVQD_______________ |
| Q13017 | Y1109 | Sugiyama | ARHGAP5 RHOGAP5 | DNyAEPIDTIFKQKGYsDEIyVVPDDsQNRIKIRNsFVNNt |
| Q13069 | Y10 | Sugiyama | GAGE5 | ___________MSWRGRsTyyWPRPRRYVQPPEVIGPMRPE |
| Q13069 | Y9 | Sugiyama | GAGE5 | ____________MSWRGRsTyyWPRPRRYVQPPEVIGPMRP |
| Q13070 | Y10 | Sugiyama | GAGE6 | ___________MSWRGRsTyyWPRPRRYVQPPEVIGPMRPE |
| Q13070 | Y9 | Sugiyama | GAGE6 | ____________MSWRGRsTyyWPRPRRYVQPPEVIGPMRP |
| Q13177 | Y139 | Sugiyama | PAK2 | NPQAVLDVLKFyDsNtVKQKyLsFtPPEKDGFPsGtPALNA |
| Q13242 | Y152 | Sugiyama | SRSF9 SFRS9 SRP30C | REAGDVCYADVQKDGVGMVEyLRKEDMEYALRKLDDTKFRs |
| Q13242 | Y17 | Sugiyama | SRSF9 SFRS9 SRP30C | ____MsGWADERGGEGDGRIyVGNLPTDVREKDLEDLFyKY |
| Q13242 | Y35 | Sugiyama | SRSF9 SFRS9 SRP30C | RIyVGNLPTDVREKDLEDLFyKYGRIREIELKNRHGLVPFA |
| Q13263 | Y133 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | TVVDCPVCKQQCFSKDIVENyFMRDsGsKAATDAQDANQCC |
| Q13263 | Y517 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | LtADsQPPVFKVFPGsttEDyNLIVIERGAAAAATGQPGtA |
| Q13263 | Y755 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | GGTLDLTLIRARLQEKLsPPyssPQEFAQDVGRMFKQFNKL |
| Q13283 | Y125 | Sugiyama | G3BP1 G3BP | LRRFMQtFVLAPEGsVANKFyVHNDIFRyQDEVFGGFVtEP |
| Q13283 | Y19 | Sugiyama | G3BP1 G3BP | __MVMEKPsPLLVGREFVRQyytLLNQAPDMLHRFYGKNss |
| Q13310 | Y194 | Sugiyama | PABPC4 APP1 PABP4 | KSRKEREAELGAKAKEFtNVyIKNFGEEVDDEsLKELFsQF |
| Q13310 | Y291 | Sugiyama | PABPC4 APP1 PABP4 | ERQAELKRKFEQLKQERISRyQGVNLyIKNLDDTIDDEKLR |
| Q13310 | Y297 | Sugiyama | PABPC4 APP1 PABP4 | KRKFEQLKQERISRyQGVNLyIKNLDDTIDDEKLRKEFsPF |
| Q13405 | Y45 | Sugiyama | MRPL49 C11orf4 NOF1 OK/SW-cl.67 | LLSQTQGPPDYPRFVEsVDEyQFVERLLPATRIPDPPKHEH |
| Q13435 | Y591 | Sugiyama | SF3B2 SAP145 | LHDAFFKWQTKPKLTIHGDLyyEGKEFETRLKEKKPGDLSD |
| Q13435 | Y592 | Sugiyama | SF3B2 SAP145 | HDAFFKWQTKPKLTIHGDLyyEGKEFETRLKEKKPGDLSDE |
| Q13442 | S19 | Sugiyama | PDAP1 HASPP28 | __MPKGGRKGGHKGRARQytsPEEIDAQLQAEKQKAREEEE |
| Q13442 | Y17 | Sugiyama | PDAP1 HASPP28 | ____MPKGGRKGGHKGRARQytsPEEIDAQLQAEKQKAREE |
| Q13442 | Y70 | Sugiyama | PDAP1 HASPP28 | DPKKEKKsLDsDEsEDEEDDyQQKRKGVEGLIDIENPNRVA |
| Q13546 | Y384 | Sugiyama | RIPK1 RIP RIP1 | EHPQEENEPSLQSKLQDEANyHLyGsRMDRQTKQQPRQNVA |
| Q13561 | Y6 | Sugiyama | DCTN2 DCTN50 | _______________MADPKyADLPGIARNEPDVYETSDLP |
| Q13573 | Y430 | Sugiyama | SNW1 SKIIP SKIP | RLFNQSKGMDSGFAGGEDEIyNVyDQAWRGGKDMAQsIyRP |
| Q13573 | Y433 | Sugiyama | SNW1 SKIIP SKIP | NQSKGMDSGFAGGEDEIyNVyDQAWRGGKDMAQsIyRPSKN |
| Q13573 | Y448 | Sugiyama | SNW1 SKIIP SKIP | EIyNVyDQAWRGGKDMAQsIyRPSKNLDKDMyGDDLEARIK |
| Q13601 | Y287 | Sugiyama | KRR1 HRB2 | tPFPPPQPESQIDKELAsGEyFLKANQKKRQKMEAIKAKQA |
| Q13642 | Y149 | Sugiyama | FHL1 SLIM1 | CSNCKQVIGtGSFFPKGEDFyCVtCHETKFAKHCVKCNKAI |
| Q13765 | Y120 | Sugiyama | NACA HSD48 | KNILFVITKPDVYKSPAsDtyIVFGEAKIEDLsQQAQLAAA |
| Q14152 | Y697 | Sugiyama | EIF3A EIF3S10 KIAA0139 | LEKEKKELQERLKNQEKKIDyFERAKRLEEIPLIKSAYEEQ |
| Q14192 | Y97 | Sugiyama | FHL2 DRAL SLIM3 | DKPFAAKEDQLLCTDCySNEySSKCQECKKTIMPGTRKMEY |
| Q14240 | Y71 | Sugiyama | EIF4A2 DDX2B EIF4F | yGFEKPsAIQQRAIIPCIKGyDVIAQAQsGtGKTATFAISI |
| Q14247 | Y289 | Sugiyama | CTTN EMS1 | FGGKFGVQsERQDsAAVGFDyKEKLAKHEsQQDySKGFGGK |
| Q14247 | Y334 | Sugiyama | CTTN EMS1 | KDRMDKNAstFEDVtQVssAyQKTVPVEAVtsKtsNIRANF |
| Q14247 | Y421 | Sugiyama | CTTN EMS1 | tPPVsPAPQPtEERLPssPVyEDAAsFKAELsyRGPVsGtE |
| Q14247 | Y538 | Sugiyama | CTTN EMS1 | IITNIEMIDDGWWRGVCKGRyGLFPANyVELRQ________ |
| Q14247 | Y545 | Sugiyama | CTTN EMS1 | IDDGWWRGVCKGRyGLFPANyVELRQ_______________ |
| Q14257 | Y311 | Sugiyama | RCN2 ERC55 | NPDLFLtsEAtDyGRQLHDDyFyHDEL______________ |
| Q14257 | Y313 | Sugiyama | RCN2 ERC55 | DLFLtsEAtDyGRQLHDDyFyHDEL________________ |
| Q14257 | Y54 | Sugiyama | RCN2 ERC55 | ERRsDyDREALLGVQEDVDEyVKLGHEEQQKRLQAIIKKID |
| Q14444 | Y99 | Sugiyama | CAPRIN1 GPIAP1 GPIP137 M11S1 RNG105 | QERMNKGERLNQDQLDAVsKyQEVtNNLEFAKELQRsFMAL |
| Q14566 | Y810 | Sugiyama | MCM6 | LTQAGLKGstEGsEsYEEDPyLVVNPNyLLED_________ |
| Q14568 | Y160 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | SAYLVAEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGERM |
| Q14568 | Y283 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | sDEEEEKKDGDKKKKKTKEKyIDQEELNKTKPIWTRNPDDI |
| Q14671 | Y83 | Sugiyama | PUM1 KIAA0099 PUMH1 | SPVPGSIGVAGRsQDDAMVDyFFQRQHGEQLGGGGsGGGGy |
| Q14974 | Y529 | Sugiyama | KPNB1 NTF97 | KLLETTDRPDGHQNNLRSSAyEsLMEIVKNSAKDCYPAVQK |
| Q15024 | Y13 | Sugiyama | EXOSC7 KIAA0116 RRP42 | ________MASVTLSEAEKVyIVHGVQEDLRVDGRGCEDYR |
| Q15056 | Y101 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | FKGFCyVEFDEVDsLKEALtyDGALLGDRsLRVDIAEGRKQ |
| Q15067 | Y239 | Sugiyama | ACOX1 ACOX | PGITVGDIGPKFGyDEIDNGyLKMDNHRIPRENMLMKYAQV |
| Q15080 | S67 | Sugiyama | NCF4 SH3PXD4 | TKGGSKYLIYRRYRQFHALQsKLEERFGPDSKSSALACTLP |
| Q15181 | Y169 | Sugiyama | PPA1 IOPPP PP | EGETDWKVIAINVDDPDAANyNDINDVKRLKPGYLEATVDW |
| Q15293 | Y278 | Sugiyama | RCN1 RCN | LNKDGKLDKDEIRHWILPQDyDHAQAEARHLVyESDKNKDE |
| Q15369 | Y18 | Sugiyama | ELOC TCEB1 | ___MDGEEKtyGGCEGPDAMyVKLISSDGHEFIVKREHALt |
| Q15369 | Y8 | Sugiyama | ELOC TCEB1 | _____________MDGEEKtyGGCEGPDAMyVKLISSDGHE |
| Q15424 | Y723 | Sugiyama | SAFB HAP HET SAFB1 | EQERRPAVRRPYDLDRRDDAyWPEAKRAALDERYHSDFNRQ |
| Q15427 | Y16 | Sugiyama | SF3B4 SAP49 | _____MAAGPISERNQDAtVyVGGLDEKVSEPLLWELFLQA |
| Q15459 | Y456 | Sugiyama | SF3A1 SAP114 | PRWLEQRDRSIREKQsDDEVyAPGLDIESsLKQLAERRtDI |
| Q15527 | Y123 | Sugiyama | SURF2 | GRRYQRALCKYEECQKQGVEyVPACLVHRRRRREDQMDGDG |
| Q15555 | Y268 | Sugiyama | MAPRE2 RP1 | NEQVHsLKLALEGVEKERDFyFGKLREIELLCQEHGQENDD |
| Q15637 | Y87 | Sugiyama | SF1 ZFM1 ZNF162 | tGDLGIPPNPEDRsPsPEPIyNsEGKRLNTREFRTRKKLEE |
| Q15691 | Y217 | Sugiyama | MAPRE1 | MQQVNVLKLtVEDLEKERDFyFGKLRNIELICQENEGENDP |
| Q16595 | Y95 | Sugiyama | FXN FRDA X25 | LMNLRKsGtLGHPGsLDEttyERLAEETLDSLAEFFEDLAD |
| Q16719 | S443 | Sugiyama | KYNU | VVCDKRNPNGIRVAPVPLyNsFHDVyKFTNLLtsILDsAET |
| Q16719 | Y441 | Sugiyama | KYNU | RGVVCDKRNPNGIRVAPVPLyNsFHDVyKFTNLLtsILDsA |
| Q16719 | Y448 | Sugiyama | KYNU | RNPNGIRVAPVPLyNsFHDVyKFTNLLtsILDsAETKN___ |
| Q16719 | Y47 | Sugiyama | KYNU | ERVALHLDEEDKLRHFRECFyIPKIQDLPPVDLSLVNKDEN |
| Q16719 | Y86 | Sugiyama | KYNU | ENAIYFLGNSLGLQPKMVKtyLEEELDKWAKIAAYGHEVGK |
| Q16778 | Y41 | Sugiyama | H2BC21 H2BFQ HIST2H2BE | KAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGIssKAMG |
| Q16778 | Y43 | Sugiyama | H2BC21 H2BFQ HIST2H2BE | QKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGIssKAMGIM |
| Q4VXU2 | Y291 | Sugiyama | PABPC1L C20orf119 | ERQNELKRRFEQMKQDRLRRyQGVNLyVKNLDDSIDDDKLR |
| Q4VXU2 | Y297 | Sugiyama | PABPC1L C20orf119 | KRRFEQMKQDRLRRyQGVNLyVKNLDDSIDDDKLRKEFSPY |
| Q53H82 | Y121 | Sugiyama | LACTB2 CGI-83 | IKKLPRNPQREEIIGNGEQQyVyLKDGDVIKTEGATLRVLY |
| Q562R1 | Y189 | Sugiyama | ACTBL2 | GYALPHAILRLDLAGRDLTDyLMKILTERGYNFTTTAEREI |
| Q562R1 | Y241 | Sugiyama | ACTBL2 | ALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPEA |
| Q58FF3 | Y58 | Sugiyama | HSP90B2P GRP94B GRP94P1 TRAP1 | VTFKSILFVPTFVPRGLFDEyGsKKSDYIKLYVRCVFITDD |
| Q58FF6 | Y32 | Sugiyama | HSP90AB4P | KEIFLQELISNASDALDKIRyEsLtDPsKLDGGKELKIDII |
| Q58FF7 | Y492 | Sugiyama | HSP90AB3P HSP90BC | TANMEQIMKAQALRDNstMGyMMAKKHLEINPDHPIMETLR |
| Q58FF7 | Y56 | Sugiyama | HSP90AB3P HSP90BC | EEIFLQELISNASDALDKIRyEsLtDPsKLDsGKELKIDII |
| Q58FF8 | Y198 | Sugiyama | HSP90AB2P HSP90BB | DEEDDsGKDKKKKTKKIKEKyIDQEELNKTKPIWTRNTEDI |
| Q58FF8 | Y260 | Sugiyama | HSP90AB2P HSP90BB | VRYFSVEEYVSRMKEIQKsIyyItGEsKEQVANSAFVEQVW |
| Q58FF8 | Y261 | Sugiyama | HSP90AB2P HSP90BB | RYFSVEEYVSRMKEIQKsIyyItGEsKEQVANSAFVEQVWK |
| Q58FF8 | Y56 | Sugiyama | HSP90AB2P HSP90BB | KEIFLWELISNASDALDKIRyEsLtDPsKLDsGKELKIDII |
| Q58FG0 | Y177 | Sugiyama | HSP90AA5P HSP90AE | GQLEELKDSRRVMKANQKHIyyItGETKDQVANSAFVECLQ |
| Q58FG0 | Y178 | Sugiyama | HSP90AA5P HSP90AE | QLEELKDSRRVMKANQKHIyyItGETKDQVANSAFVECLQK |
| Q5QNW6 | Y41 | Sugiyama | H2BC18 HIST2H2BF | KVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q5QNW6 | Y43 | Sugiyama | H2BC18 HIST2H2BF | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| Q5SW79 | Y364 | Sugiyama | CEP170 FAM68A KAB KIAA0470 | QMLWERTEEDsKsIKsDVPVyLKRLKGNKHDDGtQsDsENA |
| Q5VTE0 | Y29 | Sugiyama | EEF1A1P5 EEF1AL3 | NIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKFEKEAAEM |
| Q5VTE0 | Y85 | Sugiyama | EEF1A1P5 EEF1AL3 | AERERGITIDISLWKFEtsKyyVtIIDAPGHRDFIKNMITG |
| Q5VV41 | Y216 | Sugiyama | ARHGEF16 EPHEXIN4 NBR | KKTLGRKRGHKGsFKDDPQLyQEIQERGLNtsQEsDDDILD |
| Q6DN03 | Y41 | Sugiyama | H2BC20P HIST2H2BC | KAQKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWCKAMG |
| Q6DN03 | Y43 | Sugiyama | H2BC20P HIST2H2BC | QKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWCKAMGIM |
| Q6DRA6 | Y41 | Sugiyama | H2BC19P HIST2H2BD | KAQKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWCKAMG |
| Q6DRA6 | Y43 | Sugiyama | H2BC19P HIST2H2BD | QKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWCKAMGIM |
| Q6P1L8 | Y51 | Sugiyama | MRPL14 MRPL32 RPML32 | AIQKMTRVRVVDNSALGNsPyHRAPRCIHVYKKNGVGKVGD |
| Q6PEY2 | T225 | Sugiyama | TUBA3E | DNEAIYDICRRNLDIERPtytNLNRLIGQIVSSITASLRFD |
| Q6PKG0 | Y361 | Sugiyama | LARP1 KIAA0731 LARP | GRGRGRGRGRGRGGTRtHFDyQFGyRKFDGVEGPRtPKYMN |
| Q6PKG0 | Y365 | Sugiyama | LARP1 KIAA0731 LARP | GRGRGRGRGGTRtHFDyQFGyRKFDGVEGPRtPKYMNNITY |
| Q6PKG0 | Y699 | Sugiyama | LARP1 KIAA0731 LARP | INDGLFyyEQDLWAEKFEPEysQIKQEVENFKKVNMISREQ |
| Q6PKG0 | Y777 | Sugiyama | LARP1 KIAA0731 LARP | APEPstIARsLPttVPEsPNyRNtRtPRtPRtPQLKDSSQT |
| Q6S8J3 | Y1062 | Sugiyama | POTEE A26C1A POTE2 | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| Q6S8J3 | Y940 | Sugiyama | POTEE A26C1A POTE2 | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| Q71RC2 | Y425 | Sugiyama | LARP4 PP13296 | SRNFPAERHNPTVTGHQEQtyLQKETSTLQVEQNGDYGRGR |
| Q71U36 | S439 | Sugiyama | TUBA1A TUBA3 | SEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy________ |
| Q71U36 | T225 | Sugiyama | TUBA1A TUBA3 | DNEAIYDICRRNLDIERPtytNLNRLIGQIVSSITASLRFD |
| Q71U36 | Y432 | Sugiyama | TUBA1A TUBA3 | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| Q71U36 | Y451 | Sugiyama | TUBA1A TUBA3 | DyEEVGVDsVEGEGEEEGEEy____________________ |
| Q7KZF4 | Y109 | Sugiyama | SND1 TDRD11 | KLIGKEVCFtIENKtPQGREyGMIyLGKDTNGENIAEsLVA |
| Q7KZF4 | Y113 | Sugiyama | SND1 TDRD11 | KEVCFtIENKtPQGREyGMIyLGKDTNGENIAEsLVAEGLA |
| Q7KZF4 | Y476 | Sugiyama | SND1 TDRD11 | SKGLATVIRYRQDDDQRssHyDELLAAEARAIKNGKGLHSK |
| Q86SX6 | Y85 | Sugiyama | GLRX5 C14orf87 | PQCGFSNAVVQILRLHGVRDyAAyNVLDDPELRQGIKDYSN |
| Q86SX6 | Y88 | Sugiyama | GLRX5 C14orf87 | GFSNAVVQILRLHGVRDyAAyNVLDDPELRQGIKDYSNWPT |
| Q86V81 | Y250 | Sugiyama | ALYREF ALY BEF THOC4 | AGRNSKQQLsAEELDAQLDAyNARMDts_____________ |
| Q8N0Y7 | S137 | Sugiyama | PGAM4 PGAM3 | RsyDVPPPPMEPDHPFysNIsKDRRYADLTEDQLPSYESPK |
| Q8N0Y7 | Y92 | Sugiyama | PGAM4 PGAM3 | DAIDQMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEAQV |
| Q8N1G4 | Y257 | Sugiyama | LRRC47 KIAA1185 | LRDKRLEKMVSGCQTRSILEyLRVGGRGGGKGKGRAEGSEK |
| Q8N257 | Y41 | Sugiyama | H2BC26 H2BU1 HIST3H2BB | KAQKKDGKKRKRGRKEsysIyVyKVLKQVHPDTGIssKAMG |
| Q8N257 | Y43 | Sugiyama | H2BC26 H2BU1 HIST3H2BB | QKKDGKKRKRGRKEsysIyVyKVLKQVHPDTGIssKAMGIM |
| Q8N5P1 | Y97 | Sugiyama | ZC3H8 ZC3HDC8 | sDNDICsQEsEDNFAKELQQyIQAREMANAAQPEESTKKEG |
| Q8N6H7 | Y278 | Sugiyama | ARFGAP2 ZNF289 Nbla10535 | QAADAKKQAEESMVASMRLAyQELQIDRKKEEKKLQNLEGK |
| Q8N7H5 | Y169 | Sugiyama | PAF1 PD2 | EKPEVKIGVSVKQQFTEEEIyKDRDSQITAIEKTFEDAQKS |
| Q8NBS9 | Y251 | Sugiyama | TXNDC5 TLP46 UNQ364/PRO700 | ALGLEHSETVKIGKVDCtQHyELCsGNQVRGyPtLLWFRDG |
| Q8ND56 | Y455 | Sugiyama | LSM14A C19orf13 FAM61A RAP55 RAP55A | RGFRGGFRGGRGGREFADFEyRKTTAFGP____________ |
| Q8NFI4 | Y185 | Sugiyama | ST13P5 FAM10A5 | NAAIQDCDRAIEINPDsAQPyKWRGKAHRLLGHWEEAAHDL |
| Q8NI22 | Y135 | Sugiyama | MCFD2 SDNSF | DELINIIDGVLRDDDKNNDGyIDyAEFAKSLQ_________ |
| Q8NI22 | Y138 | Sugiyama | MCFD2 SDNSF | INIIDGVLRDDDKNNDGyIDyAEFAKSLQ____________ |
| Q8TD19 | Y52 | Sugiyama | NEK9 KIAA1995 NEK8 NERCC | PSASQGPRAGGGAAEQEELHyIPIRVLGRGAFGEAtLyRRT |
| Q8TD19 | Y845 | Sugiyama | NEK9 KIAA1995 NEK8 NERCC | PDsPsPLsAAFsEsEKDTLPyEELQGLKVAsEAPLEHKPQV |
| Q8TEW0 | Y388 | Sugiyama | PARD3 PAR3 PAR3A | QLSQSEKNNyyssRFsPDsQyIDNRSVNSAGLHTVQRAPRL |
| Q8WVJ2 | Y145 | Sugiyama | NUDCD2 | ERFQKENPGFDFsGAEIsGNytKGGPDFsNLEK________ |
| Q8WYP5 | Y1790 | Sugiyama | AHCTF1 ELYS TMBS62 MSTP108 | QSVRKKTRKAKEISEASENIySDVRGLsQNQQIPQNsVtPR |
| Q92598 | Y641 | Sugiyama | HSPH1 HSP105 HSP110 KIAA0201 | MIMQDKLEKERNDAKNAVEEyVyEFRDKLCGPYEKFICEQD |
| Q92598 | Y643 | Sugiyama | HSPH1 HSP105 HSP110 KIAA0201 | MQDKLEKERNDAKNAVEEyVyEFRDKLCGPYEKFICEQDHQ |
| Q92900 | T1124 | Sugiyama | UPF1 KIAA0221 RENT1 | VALsQDstyQGERAyQHGGVtGLsQy_______________ |
| Q92900 | Y1118 | Sugiyama | UPF1 KIAA0221 RENT1 | FKsQIDVALsQDstyQGERAyQHGGVtGLsQy_________ |
| Q93079 | Y41 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q93079 | Y43 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| Q969T4 | Y91 | Sugiyama | UBE2E3 UBCE4 UBCH9 | AEITLDPPPNCSAGPKGDNIyEWRSTILGPPGSVYEGGVFF |
| Q96AE4 | Y58 | Sugiyama | FUBP1 | ARQIAAKIGGDAGtsLNsNDyGyGGQKRPLEDGDQPDAKKV |
| Q96AE4 | Y625 | Sugiyama | FUBP1 | PGGQPDYSAAWAEYYRQQAAyyAQtsPQGMPQHPPAPQGQ_ |
| Q96C19 | T84 | Sugiyama | EFHD2 SWS1 | DLNQGIGEPQsPsRRVFNPytEFKEFSRKQIKDMEKMFKQy |
| Q96C90 | Y29 | Sugiyama | PPP1R14B PLCB3N PNG | GAALAAPAPGPGsGGPGPRVyFQsPPGAAGEGPGGADDEGP |
| Q96CT7 | Y38 | Sugiyama | CCDC124 | RRAEAKAAADAKKQKELEDAyWKDDDKHVMRKEQRKEEKEK |
| Q96D46 | Y459 | Sugiyama | NMD3 CGI-07 | YQDFLEDLEEDEAIRKNVNIyRDsAIPVEsDtDDEGAPRIS |
| Q96GX9 | Y57 | Sugiyama | APIP CGI-29 | HLGWVTGTGGGISLKHGDEIyIAPsGVQKERIQPEDMFVCD |
| Q96IK1 | Y82 | Sugiyama | BOD1 FAM44B | RGLFDSFRRDCLADVDTKPAyQNLRQKVDNFVStHLDKQEW |
| Q96LR5 | Y85 | Sugiyama | UBE2E2 UBCH8 | AEITLDPPPNCSAGPKGDNIyEWRSTILGPPGSVYEGGVFF |
| Q96QK1 | Y507 | Sugiyama | VPS35 MEM3 TCCCTA00141 | EQSLVGRFIHLLRsEDPDQQyLILNTARKHFGAGGNQRIRF |
| Q96QK1 | Y791 | Sugiyama | VPS35 MEM3 TCCCTA00141 | HNtLEHLRLRREsPEsEGPIyEGLIL_______________ |
| Q96T37 | Y608 | Sugiyama | RBM15 OTT OTT1 | PPPPPVRERSTRTAATsVPAyEPLDSLDRRRDGWsLDRDRG |
| Q99460 | Y494 | Sugiyama | PSMD1 | RHGGSLGLGLAAMGTARQDVyDLLKTNLYQDDAVTGEAAGL |
| Q99470 | Y187 | Sugiyama | SDF2 | GRPISGQKEVHGMAQPSQNNyWKAMEGIFMKPSELLKAEAH |
| Q99470 | Y69 | Sugiyama | SDF2 | GSGSGQQSVTGVTSVDDSNSyWRIRGKSATVCERGTPIKCG |
| Q99584 | Y76 | Sugiyama | S100A13 | LDEKMKsLDVNQDSELKFNEyWRLIGELAKEIRKKKDLKIR |
| Q99614 | S281 | Sugiyama | TTC1 TPR1 | PFGLstENFQIKQDsstGsysINFVQNPNNNR_________ |
| Q99614 | Y96 | Sugiyama | TTC1 TPR1 | ADKVENKsNEDVNssELDEEyLIELEKNMSDEEKQKRREES |
| Q99700 | Y454 | Sugiyama | ATXN2 ATX2 SCA2 TNRC13 | FLKREARANQLAEEIESsAQyKARVALENDDRsEEEKyTAV |
| Q99733 | Y85 | Sugiyama | NAP1L4 NAP2 | RRINALKQLQVRCAHIEAKFyEEVHDLERKyAALyQPLFDK |
| Q99733 | Y99 | Sugiyama | NAP1L4 NAP2 | HIEAKFyEEVHDLERKyAALyQPLFDKRREFItGDVEPtDA |
| Q99798 | Y544 | Sugiyama | ACO2 | LEAPDADELPKGEFDPGQDtyQHPPKDSsGQHVDVsPtsQR |
| Q99848 | Y265 | Sugiyama | EBNA1BP2 EBP2 | NQKFGFGGKKKGSKWNtREsyDDVssFRAKTAHGRGLKRPG |
| Q99877 | Y41 | Sugiyama | H2BC15 H2BFD HIST1H2BN | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q99877 | Y43 | Sugiyama | H2BC15 H2BFD HIST1H2BN | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| Q99879 | Y41 | Sugiyama | H2BC14 H2BFE HIST1H2BM | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q99879 | Y43 | Sugiyama | H2BC14 H2BFE HIST1H2BM | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| Q99880 | Y41 | Sugiyama | H2BC13 H2BFC HIST1H2BL | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q99880 | Y43 | Sugiyama | H2BC13 H2BFC HIST1H2BL | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| Q99961 | Y57 | Sugiyama | SH3GL1 CNSA1 SH3D2B | EKKVDVTSKAVTEVLARTIEyLQPNPAsRAKLTMLNTVSKI |
| Q99962 | Y57 | Sugiyama | SH3GL2 CNSA2 SH3D2A | ERKVDVTSRAVMEIMTKTIEyLQPNPAsRAKLSMINTMsKI |
| Q9BQE3 | T225 | Sugiyama | TUBA1C TUBA6 | DNEAIYDICRRNLDIERPtytNLNRLIsQIVSsITASLRFD |
| Q9BQE3 | Y432 | Sugiyama | TUBA1C TUBA6 | GMEEGEFSEAREDMAALEKDyEEVGADsADGEDEGEEy___ |
| Q9BQE3 | Y449 | Sugiyama | TUBA1C TUBA6 | EKDyEEVGADsADGEDEGEEy____________________ |
| Q9BRL6 | Y44 | Sugiyama | SRSF8 SFRS2B SRP46 | RtsPDsLRRVFEKYGRVGDVyIPREPHTKAPRGFAFVRFHD |
| Q9BS40 | Y20 | Sugiyama | LXN | _MEIPPTNYPASRAALVAQNyINyQQGTPHRVFEVQKVKQA |
| Q9BS40 | Y23 | Sugiyama | LXN | IPPTNYPASRAALVAQNyINyQQGTPHRVFEVQKVKQAsME |
| Q9BSU3 | Y145 | Sugiyama | NAA11 ARD1B ARD2 | TLNFQISEVEPKyyADGEDAyAMKRDLSQMADELRRQMDLK |
| Q9BTD8 | Y424 | Sugiyama | RBM42 | FPsFLKAKVIRDKRTGKTKGyGFVSFKDPsDyVRAMREMNG |
| Q9BTD8 | Y435 | Sugiyama | RBM42 | DKRTGKTKGyGFVSFKDPsDyVRAMREMNGKYVGSRPIKLR |
| Q9BVP2 | Y548 | Sugiyama | GNL3 E2IG3 NS | RSFILDKIIEEDDAyDFSTDyV___________________ |
| Q9BWG6 | Y193 | Sugiyama | SCNM1 | sAtVsAPAPMsPtRRRALDHyLTLRSsGWIPDGRGRWVKDE |
| Q9BYX7 | Y240 | Sugiyama | POTEKP ACTBL3 FKSG30 | ALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPEA |
| Q9BYX7 | Y362 | Sugiyama | POTEKP ACTBL3 FKSG30 | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| Q9BZZ5 | Y28 | Sugiyama | API5 MIG8 | YRNyGILADATEQVGQHKDAyQVILDGVKGGTKEKRLAAQF |
| Q9H1E3 | Y146 | Sugiyama | NUCKS1 NUCKS JC7 | QEKDsGsDEDFLMEDDDDsDyGSsKKKNKKMVKKSKPERKE |
| Q9H814 | Y152 | Sugiyama | PHAX RNUXA | TELGILGMEGTIDRsRQsEtyNyLLAKKLRKESQEHTKDLD |
| Q9H814 | Y154 | Sugiyama | PHAX RNUXA | LGILGMEGTIDRsRQsEtyNyLLAKKLRKESQEHTKDLDKE |
| Q9H814 | Y57 | Sugiyama | PHAX RNUXA | GDsAMRAFQNTAtACAPVSHyRAVESVDSSEESFSDSDDDS |
| Q9HAU0 | Y436 | Sugiyama | PLEKHA5 KIAA1686 PEPP2 | QWIKIQKGRGHEEETRGVISyQtLPRNMPSHRAQIMARYPE |
| Q9HB07 | Y189 | Sugiyama | MYG1 C12orf10 | VEEVDAVDNGISQWAEGEPRyALttTLsARVARLNPTWNHP |
| Q9HCN8 | Y81 | Sugiyama | SDF2L1 UNQ1941/PRO4424 | GSGSGQQSVtGVEAsDDANSyWRIRGGSEGGCPRGSPVRCG |
| Q9HDC5 | Y417 | Sugiyama | JPH1 JP1 | AARQECDIARAVARELsPDFyQPGPDyVKQRFQEGVDAKEN |
| Q9HDC5 | Y423 | Sugiyama | JPH1 JP1 | DIARAVARELsPDFyQPGPDyVKQRFQEGVDAKENPEEKVP |
| Q9NP61 | Y432 | Sugiyama | ARFGAP3 ARFGAP1 | ENTDEAQKKFGNVKAIssDMyFGRQsQADYETRARLERLsA |
| Q9NP74 | Y257 | Sugiyama | PALMD C1orf11 PALML | VEVEELLRQASERNsKsPtEyHEPVyANPFyRPttPQREtV |
| Q9NP74 | Y262 | Sugiyama | PALMD C1orf11 PALML | LLRQASERNsKsPtEyHEPVyANPFyRPttPQREtVtPGPN |
| Q9NR56 | Y68 | Sugiyama | MBNL1 EXP KIAA0428 MBNL | GRVIACFDsLKGRCSRENCKyLHPPPHLKTQLEINGRNNLI |
| Q9NRX4 | Y116 | Sugiyama | PHPT1 PHP14 CGI-202 HSPC141 | AyGPAQHAISTEKIKAKyPDyEVtWANDGy___________ |
| Q9NRX4 | Y52 | Sugiyama | PHPT1 PHP14 CGI-202 HSPC141 | RSGAPAAESKEIVRGYKWAEyHADIyDKVSGDMQKQGCDCE |
| Q9NRX4 | Y57 | Sugiyama | PHPT1 PHP14 CGI-202 HSPC141 | AAESKEIVRGYKWAEyHADIyDKVSGDMQKQGCDCECLGGG |
| Q9NUK0 | Y69 | Sugiyama | MBNL3 CHCR MBLX39 MBXL | GRVVACFDSLKGRCTRENCKyLHPPPHLKTQLEINGRNNLI |
| Q9NVS9 | Y256 | Sugiyama | PNPO | LPtGDsPLGPMTHRGEEDWLyERLAP_______________ |
| Q9NWS0 | Y194 | Sugiyama | PIH1D1 NOP17 | IsQQNIRSEQRPRIQELGDLytPAPGRAESGPEKPHLNLWL |
| Q9NY65 | T225 | Sugiyama | TUBA8 TUBAL2 | DNEAIYDICRRNLDIERPtytNLNRLIsQIVSsITASLRFD |
| Q9NYF8 | Y408 | Sugiyama | BCLAF1 BTF KIAA0164 | EsGKQKFNDsEGDDtEEtEDyRQFRKsVLADQGKsFATAsH |
| Q9NYU2 | Y966 | Sugiyama | UGGT1 GT UGCGL1 UGGT UGT1 UGTR | LVMKVDALLsAQPKGDPRIEyQFFEDRHSAIKLRPKEGETY |
| Q9UBR2 | Y76 | Sugiyama | CTSZ | YLSPADLPKSWDWRNVDGVNyAsItRNQHIPQYCGSCWAHA |
| Q9UBS4 | Y74 | Sugiyama | DNAJB11 EDJ ERJ3 HDJ9 PSEC0121 UNQ537/PRO1080 | PDRNPDDPQAQEKFQDLGAAyEVLsDSEKRKQyDTyGEEGL |
| Q9UHR5 | Y165 | Sugiyama | SAP30BP HCNGP HTRG HTRP | EGMDMNyIIQRKKEFRNPsIyEKLIQFCAIDELGTNYPKDM |
| Q9UI15 | Y192 | Sugiyama | TAGLN3 NP25 | NVIGLQMGSNKGAsQAGMtGyGMPRQIM_____________ |
| Q9UJU6 | Y16 | Sugiyama | DBNL CMAP SH3P7 PP5423 | _____MAANLSRNGPALQEAyVRVVtEKsPtDWALFTyEGN |
| Q9UKS6 | Y206 | Sugiyama | PACSIN3 | RKLQERVERCAKEAEKTKAQyEQtLAELHRYTPRYMEDMEQ |
| Q9UKY7 | Y244 | Sugiyama | CDV3 H41 | NRGRDEVSKNQALKLQLDNQyAVLENQKSSHSQYN______ |
| Q9UMS0 | Y194 | Sugiyama | NFU1 HIRIP5 CGI-33 | KELLDTRIRPTVQEDGGDVIyKGFEDGIVQLKLQGSCTSCP |
| Q9UMX5 | Y65 | Sugiyama | NENF CIR2 SPUF | RLFtEEELARYGGEEEDQPIyLAVKGVVFDVtSGKEFYGRG |
| Q9UNF0 | Y267 | Sugiyama | PACSIN2 | VLLEVQKHLDLSNVAGYKAIyHDLEQsIRAADAVEDLRWFR |
| Q9UNH7 | Y220 | Sugiyama | SNX6 | VSGVKDVDDFFEHERTFLLEyHNRVKDASAKSDRMTRSHKS |
| Q9UNZ2 | Y167 | Sugiyama | NSFL1C UBXN2C | PRPFAGGGYRLGAAPEEEsAyVAGEKRQHssQDVHVVLKLW |
| Q9Y237 | S72 | Sugiyama | PIN4 | MEAMEKLKSGMRFNEVAAQysEDKARQGGDLGWMTRGSMVG |
| Q9Y265 | Y438 | Sugiyama | RUVBL1 INO80H NMP238 TIP49 TIP49A | KINGKDSIEKEHVEEIsELFyDAKSSAKILADQQDKYMK__ |
| Q9Y281 | Y82 | Sugiyama | CFL2 | DTVEDPYtsFVKLLPLNDCRyALyDAtyEtKESKKEDLVFI |
| Q9Y281 | Y85 | Sugiyama | CFL2 | EDPYtsFVKLLPLNDCRyALyDAtyEtKESKKEDLVFIFWA |
| Q9Y281 | Y89 | Sugiyama | CFL2 | tsFVKLLPLNDCRyALyDAtyEtKESKKEDLVFIFWAPESA |
| Q9Y2B0 | Y71 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | IQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEICDRMKE |
| Q9Y2W1 | T230 | Sugiyama | THRAP3 BCLAF2 TRAP150 | tsQDTKAsEssKPWPDAtyGtGsAsRAsAVsELsPRERsPA |
| Q9Y2W1 | Y228 | Sugiyama | THRAP3 BCLAF2 TRAP150 | GGtsQDTKAsEssKPWPDAtyGtGsAsRAsAVsELsPRERs |
| Q9Y2W2 | Y236 | Sugiyama | WBP11 NPWBP SIPP1 SNP70 | GRKVGFALDLPPRRRDEDMLysPELAQRGHDDDVSSTSEDD |
| Q9Y394 | S328 | Sugiyama | DHRS7 DHRS7A RETSDR4 SDR34C1 CGI-86 UNQ285/PRO3448 | ITNKMGKKRIENFKSGVDADssyFKIFKTKHD_________ |
| Q9Y394 | Y330 | Sugiyama | DHRS7 DHRS7A RETSDR4 SDR34C1 CGI-86 UNQ285/PRO3448 | NKMGKKRIENFKSGVDADssyFKIFKTKHD___________ |
| Q9Y3C1 | Y118 | Sugiyama | NOP16 CGI-117 HSPC111 | EAEASLPEKKGNTLSRDLIDyVRYMVENHGEDYKAMARDEK |
| Q9Y3F4 | Y261 | Sugiyama | STRAP MAWD UNRIP | GGEDFKLyKyDyNsGEELEsyKGHFGPIHCVRFSPDGELyA |
| Q9Y3U8 | Y53 | Sugiyama | RPL36 | LTKHTKFVRDMIREVCGFAPyERRAMELLKVSKDKRALKFI |
| Q9Y4H2 | S915 | Sugiyama | IRS2 | LEGLPSLPSMHEYPLPPEPKsPGEyINIDFGEPGARLsPPA |
| Q9Y4H2 | Y919 | Sugiyama | IRS2 | PSLPSMHEYPLPPEPKsPGEyINIDFGEPGARLsPPAPPLL |
| Q9Y5Q8 | Y393 | Sugiyama | GTF3C5 CDABP0017 | SGtsGARKPASSKYKLKDSVyIFREGALPPYRQMFYQLCDL |
| Q9Y5S9 | S56 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | KGRGFGsEEGsRARMREDyDsVEQDGDEPGPQRSVEGWILF |
| Q9Y5S9 | Y54 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | KRKGRGFGsEEGsRARMREDyDsVEQDGDEPGPQRSVEGWI |
| Q9Y696 | Y244 | Sugiyama | CLIC4 | AysRDEFtNtCPsDKEVEIAysDVAKRLTK___________ |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 9.243373e-11 | 10.034 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 5.418910e-11 | 10.266 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 2.655370e-09 | 8.576 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 5.727603e-09 | 8.242 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 1.110480e-08 | 7.954 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 3.561592e-08 | 7.448 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 8.624604e-08 | 7.064 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 1.389602e-07 | 6.857 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 1.558615e-07 | 6.807 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 3.327946e-07 | 6.478 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 5.397040e-07 | 6.268 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 1.148826e-06 | 5.940 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 2.065354e-06 | 5.685 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 2.603723e-06 | 5.584 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 2.842069e-06 | 5.546 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 3.648052e-06 | 5.438 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 8.241618e-06 | 5.084 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 8.241618e-06 | 5.084 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.343435e-05 | 4.872 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 2.232257e-05 | 4.651 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 3.688435e-05 | 4.433 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 4.194206e-05 | 4.377 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 5.549733e-05 | 4.256 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 5.998215e-05 | 4.222 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 9.549563e-05 | 4.020 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 1.017437e-04 | 3.992 | 1 | 1 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 1.137636e-04 | 3.944 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.350841e-04 | 3.869 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 1.298876e-04 | 3.886 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 1.474940e-04 | 3.831 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 1.632050e-04 | 3.787 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 1.853720e-04 | 3.732 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 1.910297e-04 | 3.719 | 0 | 0 |
| Activation of TRKA receptors | R-HSA-187015 | 2.006983e-04 | 3.697 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 2.311746e-04 | 3.636 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 2.479335e-04 | 3.606 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 2.857689e-04 | 3.544 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 3.030435e-04 | 3.518 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 3.243943e-04 | 3.489 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 3.254984e-04 | 3.487 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 3.683567e-04 | 3.434 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 4.962603e-04 | 3.304 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 5.332534e-04 | 3.273 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 5.332534e-04 | 3.273 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 5.332534e-04 | 3.273 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 6.506227e-04 | 3.187 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 6.540124e-04 | 3.184 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 6.540124e-04 | 3.184 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 6.540124e-04 | 3.184 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 7.832908e-04 | 3.106 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 7.258278e-04 | 3.139 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 7.832908e-04 | 3.106 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 7.701638e-04 | 3.113 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 8.249713e-04 | 3.084 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 9.745830e-04 | 3.011 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 1.007679e-03 | 2.997 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.097492e-03 | 2.960 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.217071e-03 | 2.915 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.217071e-03 | 2.915 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 1.409499e-03 | 2.851 | 0 | 0 |
| Signaling by FGFR1 amplification mutants | R-HSA-1839120 | 1.448385e-03 | 2.839 | 0 | 0 |
| TRKA activation by NGF | R-HSA-187042 | 1.448385e-03 | 2.839 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 1.940506e-03 | 2.712 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 1.940506e-03 | 2.712 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 1.940506e-03 | 2.712 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 2.070689e-03 | 2.684 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 2.070689e-03 | 2.684 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 2.398682e-03 | 2.620 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 2.274557e-03 | 2.643 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 2.203312e-03 | 2.657 | 1 | 0 |
| Immune System | R-HSA-168256 | 2.523802e-03 | 2.598 | 1 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 2.574554e-03 | 2.589 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 2.798205e-03 | 2.553 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 3.102122e-03 | 2.508 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 3.102122e-03 | 2.508 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 2.798205e-03 | 2.553 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 2.798205e-03 | 2.553 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.783196e-03 | 2.555 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 2.759083e-03 | 2.559 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 3.587871e-03 | 2.445 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 3.587871e-03 | 2.445 | 0 | 0 |
| NGF-independant TRKA activation | R-HSA-187024 | 3.628586e-03 | 2.440 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 3.813028e-03 | 2.419 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 3.813028e-03 | 2.419 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 3.813028e-03 | 2.419 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 4.202629e-03 | 2.376 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 4.615555e-03 | 2.336 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 5.052196e-03 | 2.297 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 5.052196e-03 | 2.297 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 5.306887e-03 | 2.275 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 5.512921e-03 | 2.259 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 5.588735e-03 | 2.253 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 5.721817e-03 | 2.242 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 5.721817e-03 | 2.242 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 5.998080e-03 | 2.222 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 6.713996e-03 | 2.173 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 6.713996e-03 | 2.173 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 7.603350e-03 | 2.119 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 7.603350e-03 | 2.119 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 7.042995e-03 | 2.152 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 7.603350e-03 | 2.119 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 7.933103e-03 | 2.101 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 7.732371e-03 | 2.112 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 7.985750e-03 | 2.098 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 8.171570e-03 | 2.088 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 9.243895e-03 | 2.034 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 9.243895e-03 | 2.034 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 9.243895e-03 | 2.034 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 9.243895e-03 | 2.034 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 9.243895e-03 | 2.034 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 1.093189e-02 | 1.961 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 1.093189e-02 | 1.961 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 1.093189e-02 | 1.961 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 1.093189e-02 | 1.961 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 1.093189e-02 | 1.961 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 1.093189e-02 | 1.961 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 1.093189e-02 | 1.961 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 1.213206e-02 | 1.916 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 1.213206e-02 | 1.916 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.213206e-02 | 1.916 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.151198e-02 | 1.939 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 1.151198e-02 | 1.939 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 1.064424e-02 | 1.973 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 1.225645e-02 | 1.912 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.273030e-02 | 1.895 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.370528e-02 | 1.863 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 1.370528e-02 | 1.863 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 1.370528e-02 | 1.863 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 1.370528e-02 | 1.863 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 1.370528e-02 | 1.863 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 1.370528e-02 | 1.863 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 1.370528e-02 | 1.863 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 1.455146e-02 | 1.837 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.465265e-02 | 1.834 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 1.536189e-02 | 1.814 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 1.536189e-02 | 1.814 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 1.536189e-02 | 1.814 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.638696e-02 | 1.786 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 1.672823e-02 | 1.777 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 1.709989e-02 | 1.767 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 1.891733e-02 | 1.723 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 1.891733e-02 | 1.723 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 1.891733e-02 | 1.723 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.891733e-02 | 1.723 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.081228e-02 | 1.682 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.801947e-02 | 1.744 | 1 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 1.919540e-02 | 1.717 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 2.120632e-02 | 1.674 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 2.278286e-02 | 1.642 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 2.332838e-02 | 1.632 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 2.395765e-02 | 1.621 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 2.443109e-02 | 1.612 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 2.482720e-02 | 1.605 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 2.482720e-02 | 1.605 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 2.687626e-02 | 1.571 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 2.694347e-02 | 1.570 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.694347e-02 | 1.570 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 2.694347e-02 | 1.570 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 2.771513e-02 | 1.557 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 2.912988e-02 | 1.536 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 2.912988e-02 | 1.536 | 1 | 1 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 3.005456e-02 | 1.522 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 3.138466e-02 | 1.503 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 3.138466e-02 | 1.503 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 3.138466e-02 | 1.503 | 0 | 0 |
| NTRK3 as a dependence receptor | R-HSA-9603505 | 3.244044e-02 | 1.489 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 3.244044e-02 | 1.489 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 4.301965e-02 | 1.366 | 0 | 0 |
| NTF3 activates NTRK2 (TRKB) signaling | R-HSA-9025046 | 4.301965e-02 | 1.366 | 0 | 0 |
| NTF4 activates NTRK2 (TRKB) signaling | R-HSA-9026357 | 4.301965e-02 | 1.366 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 4.301965e-02 | 1.366 | 0 | 0 |
| BDNF activates NTRK2 (TRKB) signaling | R-HSA-9024909 | 4.301965e-02 | 1.366 | 0 | 0 |
| NTF3 activates NTRK3 signaling | R-HSA-9034013 | 4.301965e-02 | 1.366 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 4.301965e-02 | 1.366 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 4.301965e-02 | 1.366 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 4.301965e-02 | 1.366 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 4.301965e-02 | 1.366 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 4.301965e-02 | 1.366 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 4.301965e-02 | 1.366 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 4.301965e-02 | 1.366 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 4.301965e-02 | 1.366 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 4.301965e-02 | 1.366 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 3.370606e-02 | 1.472 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 3.609239e-02 | 1.443 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 3.854196e-02 | 1.414 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 3.954566e-02 | 1.403 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 4.105312e-02 | 1.387 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 3.854196e-02 | 1.414 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 3.609239e-02 | 1.443 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 3.370606e-02 | 1.472 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 4.275935e-02 | 1.369 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 3.854196e-02 | 1.414 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 3.596709e-02 | 1.444 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 3.424896e-02 | 1.465 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 4.241077e-02 | 1.373 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 4.362425e-02 | 1.360 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 4.362425e-02 | 1.360 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 4.625375e-02 | 1.335 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 5.168164e-02 | 1.287 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 5.168164e-02 | 1.287 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 5.168164e-02 | 1.287 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 5.168164e-02 | 1.287 | 0 | 0 |
| Activated NTRK3 signals through PLCG1 | R-HSA-9034793 | 5.348384e-02 | 1.272 | 0 | 0 |
| PLC-gamma1 signalling | R-HSA-167021 | 5.348384e-02 | 1.272 | 0 | 0 |
| Signaling by plasma membrane FGFR1 fusions | R-HSA-8853336 | 5.348384e-02 | 1.272 | 0 | 0 |
| Signalling to STAT3 | R-HSA-198745 | 5.348384e-02 | 1.272 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 5.348384e-02 | 1.272 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 5.348384e-02 | 1.272 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 5.447696e-02 | 1.264 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 5.629874e-02 | 1.250 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 5.732455e-02 | 1.242 | 0 | 0 |
| Activated NTRK2 signals through PLCG1 | R-HSA-9026527 | 6.383425e-02 | 1.195 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 6.383425e-02 | 1.195 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 6.383425e-02 | 1.195 | 0 | 0 |
| IRS activation | R-HSA-74713 | 7.407210e-02 | 1.130 | 0 | 0 |
| FGFR1c and Klotho ligand binding and activation | R-HSA-190374 | 7.407210e-02 | 1.130 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 8.419862e-02 | 1.075 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 8.419862e-02 | 1.075 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 8.419862e-02 | 1.075 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 8.419862e-02 | 1.075 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 7.542750e-02 | 1.122 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 6.317070e-02 | 1.199 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 8.731161e-02 | 1.059 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 7.407210e-02 | 1.130 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 7.542750e-02 | 1.122 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 7.542750e-02 | 1.122 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 6.616641e-02 | 1.179 | 0 | 0 |
| PTK6 Activates STAT3 | R-HSA-8849474 | 7.407210e-02 | 1.130 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 8.836556e-02 | 1.054 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 7.407210e-02 | 1.130 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 6.383425e-02 | 1.195 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 7.387695e-02 | 1.131 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 8.390222e-02 | 1.076 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 6.920868e-02 | 1.160 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 7.407210e-02 | 1.130 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 8.419862e-02 | 1.075 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 8.560002e-02 | 1.068 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 8.181655e-02 | 1.087 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 8.181655e-02 | 1.087 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 7.907734e-02 | 1.102 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 8.419862e-02 | 1.075 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 8.419862e-02 | 1.075 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 6.442929e-02 | 1.191 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 8.181655e-02 | 1.087 | 0 | 0 |
| Disease | R-HSA-1643685 | 8.293156e-02 | 1.081 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 7.407210e-02 | 1.130 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 6.317070e-02 | 1.199 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 8.507168e-02 | 1.070 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 6.022294e-02 | 1.220 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 6.230519e-02 | 1.205 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 6.616641e-02 | 1.179 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 8.954600e-02 | 1.048 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.366670e-02 | 1.028 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 9.421501e-02 | 1.026 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 9.421501e-02 | 1.026 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 9.506467e-02 | 1.022 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 1.019043e-01 | 0.992 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 1.019043e-01 | 0.992 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 1.019043e-01 | 0.992 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 1.019043e-01 | 0.992 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 1.019043e-01 | 0.992 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.024121e-01 | 0.990 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 1.033075e-01 | 0.986 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 1.041225e-01 | 0.982 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 1.041225e-01 | 0.982 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 1.041225e-01 | 0.982 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 1.041225e-01 | 0.982 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 1.041225e-01 | 0.982 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.041225e-01 | 0.982 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 1.041225e-01 | 0.982 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 1.041225e-01 | 0.982 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 1.055652e-01 | 0.976 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 1.139221e-01 | 0.943 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 1.139221e-01 | 0.943 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 1.139221e-01 | 0.943 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.139221e-01 | 0.943 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.139221e-01 | 0.943 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.236152e-01 | 0.908 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 1.236152e-01 | 0.908 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.236152e-01 | 0.908 | 0 | 0 |
| Highly calcium permeable postsynaptic nicotinic acetylcholine receptors | R-HSA-629594 | 1.332029e-01 | 0.875 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 1.332029e-01 | 0.875 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.426862e-01 | 0.846 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.426862e-01 | 0.846 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.426862e-01 | 0.846 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.426862e-01 | 0.846 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 1.613445e-01 | 0.792 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 1.705217e-01 | 0.768 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 1.705217e-01 | 0.768 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 1.795990e-01 | 0.746 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 1.795990e-01 | 0.746 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 1.885775e-01 | 0.725 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 1.885775e-01 | 0.725 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 1.974583e-01 | 0.705 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 1.974583e-01 | 0.705 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 1.974583e-01 | 0.705 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 2.062424e-01 | 0.686 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 2.149310e-01 | 0.668 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 1.088754e-01 | 0.963 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 1.159689e-01 | 0.936 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.491836e-01 | 0.826 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.568062e-01 | 0.805 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 1.570396e-01 | 0.804 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 1.570396e-01 | 0.804 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 2.038331e-01 | 0.691 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.332029e-01 | 0.875 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 1.885775e-01 | 0.725 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 1.974583e-01 | 0.705 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 1.147873e-01 | 0.940 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 1.520664e-01 | 0.818 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 1.613445e-01 | 0.792 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 1.705217e-01 | 0.768 | 0 | 0 |
| TET1,2,3 and TDG demethylate DNA | R-HSA-5221030 | 1.332029e-01 | 0.875 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 1.139221e-01 | 0.943 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 1.613445e-01 | 0.792 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 1.139221e-01 | 0.943 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 2.118295e-01 | 0.674 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 1.139221e-01 | 0.943 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 1.332029e-01 | 0.875 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 1.426862e-01 | 0.846 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.426862e-01 | 0.846 | 0 | 0 |
| Conjugation of benzoate with glycine | R-HSA-177135 | 1.426862e-01 | 0.846 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.520664e-01 | 0.818 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 1.520664e-01 | 0.818 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 1.613445e-01 | 0.792 | 0 | 0 |
| Conjugation of salicylate with glycine | R-HSA-177128 | 1.613445e-01 | 0.792 | 0 | 0 |
| Postsynaptic nicotinic acetylcholine receptors | R-HSA-622327 | 1.705217e-01 | 0.768 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 1.705217e-01 | 0.768 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.885775e-01 | 0.725 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 1.974583e-01 | 0.705 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 1.974583e-01 | 0.705 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.606450e-01 | 0.794 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 1.683734e-01 | 0.774 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 1.416402e-01 | 0.849 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 1.613445e-01 | 0.792 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 2.149310e-01 | 0.668 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.705217e-01 | 0.768 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 1.236152e-01 | 0.908 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 1.644056e-01 | 0.784 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 1.761641e-01 | 0.754 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.236152e-01 | 0.908 | 0 | 0 |
| Acetylcholine binding and downstream events | R-HSA-181431 | 1.705217e-01 | 0.768 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 1.195589e-01 | 0.922 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 1.645010e-01 | 0.784 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 1.378303e-01 | 0.861 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 2.062424e-01 | 0.686 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 2.038331e-01 | 0.691 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.722613e-01 | 0.764 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 1.340928e-01 | 0.873 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 1.613445e-01 | 0.792 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 1.705217e-01 | 0.768 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 1.705217e-01 | 0.768 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 1.302379e-01 | 0.885 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 1.124073e-01 | 0.949 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 1.885775e-01 | 0.725 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.722613e-01 | 0.764 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 1.795990e-01 | 0.746 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 1.885775e-01 | 0.725 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 1.885775e-01 | 0.725 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 1.304895e-01 | 0.884 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.124073e-01 | 0.949 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 1.974583e-01 | 0.705 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 1.606450e-01 | 0.794 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 1.289756e-01 | 0.889 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 2.118295e-01 | 0.674 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.330679e-01 | 0.876 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 2.032550e-01 | 0.692 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.332029e-01 | 0.875 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 1.341833e-01 | 0.872 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.702800e-01 | 0.769 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 2.004502e-01 | 0.698 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 2.062424e-01 | 0.686 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 1.332029e-01 | 0.875 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.139221e-01 | 0.943 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.236152e-01 | 0.908 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.885775e-01 | 0.725 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.665096e-01 | 0.779 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.948693e-01 | 0.710 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.411403e-01 | 0.850 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 2.149310e-01 | 0.668 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 1.547224e-01 | 0.810 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 1.705217e-01 | 0.768 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 2.149310e-01 | 0.668 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 1.568062e-01 | 0.805 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 1.795990e-01 | 0.746 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.195589e-01 | 0.922 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 2.174122e-01 | 0.663 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 2.202686e-01 | 0.657 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.235249e-01 | 0.651 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 2.235249e-01 | 0.651 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.235249e-01 | 0.651 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 2.235249e-01 | 0.651 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 2.235249e-01 | 0.651 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 2.235249e-01 | 0.651 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 2.279085e-01 | 0.642 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 2.279085e-01 | 0.642 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 2.317249e-01 | 0.635 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 2.319426e-01 | 0.635 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 2.320254e-01 | 0.634 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 2.320254e-01 | 0.634 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 2.320254e-01 | 0.634 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 2.320254e-01 | 0.634 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 2.320254e-01 | 0.634 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 2.320254e-01 | 0.634 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 2.320254e-01 | 0.634 | 0 | 0 |
| Conjugation of carboxylic acids | R-HSA-159424 | 2.320254e-01 | 0.634 | 0 | 0 |
| Amino Acid conjugation | R-HSA-156587 | 2.320254e-01 | 0.634 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 2.320254e-01 | 0.634 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 2.320254e-01 | 0.634 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 2.320254e-01 | 0.634 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.337315e-01 | 0.631 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 2.359812e-01 | 0.627 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 2.404332e-01 | 0.619 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 2.404332e-01 | 0.619 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 2.404332e-01 | 0.619 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 2.404332e-01 | 0.619 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 2.404658e-01 | 0.619 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 2.440698e-01 | 0.612 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 2.481187e-01 | 0.605 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 2.487496e-01 | 0.604 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 2.487496e-01 | 0.604 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 2.492172e-01 | 0.603 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 2.492172e-01 | 0.603 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 2.492172e-01 | 0.603 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 2.521698e-01 | 0.598 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 2.524702e-01 | 0.598 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 2.524702e-01 | 0.598 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 2.569754e-01 | 0.590 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 2.569754e-01 | 0.590 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.569754e-01 | 0.590 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 2.569754e-01 | 0.590 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 2.569754e-01 | 0.590 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 2.569754e-01 | 0.590 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 2.569754e-01 | 0.590 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 2.580167e-01 | 0.588 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 2.597537e-01 | 0.585 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 2.600665e-01 | 0.585 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 2.609594e-01 | 0.583 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 2.651116e-01 | 0.577 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 2.651116e-01 | 0.577 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 2.651116e-01 | 0.577 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 2.668608e-01 | 0.574 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 2.726816e-01 | 0.564 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 2.731592e-01 | 0.564 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 2.731592e-01 | 0.564 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 2.731592e-01 | 0.564 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.731592e-01 | 0.564 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 2.731592e-01 | 0.564 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 2.805490e-01 | 0.552 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 2.805490e-01 | 0.552 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 2.811192e-01 | 0.551 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 2.811192e-01 | 0.551 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 2.816710e-01 | 0.550 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 2.846003e-01 | 0.546 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 2.846003e-01 | 0.546 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 2.857449e-01 | 0.544 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 2.886496e-01 | 0.540 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 2.889925e-01 | 0.539 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 2.889925e-01 | 0.539 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 2.889925e-01 | 0.539 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 2.889925e-01 | 0.539 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 2.889925e-01 | 0.539 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 2.889925e-01 | 0.539 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 2.905956e-01 | 0.537 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 2.911604e-01 | 0.536 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 2.929200e-01 | 0.533 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 2.935753e-01 | 0.532 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 2.967801e-01 | 0.528 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 2.967801e-01 | 0.528 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 3.044829e-01 | 0.516 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 3.044829e-01 | 0.516 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 3.044829e-01 | 0.516 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 3.044829e-01 | 0.516 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 3.044829e-01 | 0.516 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 3.048171e-01 | 0.516 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 3.121017e-01 | 0.506 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 3.121017e-01 | 0.506 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 3.121017e-01 | 0.506 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 3.121017e-01 | 0.506 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 3.121017e-01 | 0.506 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 3.121017e-01 | 0.506 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 3.196376e-01 | 0.495 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 3.196376e-01 | 0.495 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 3.196376e-01 | 0.495 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 3.249300e-01 | 0.488 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 3.258723e-01 | 0.487 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 3.270913e-01 | 0.485 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 3.270913e-01 | 0.485 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 3.270913e-01 | 0.485 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 3.289359e-01 | 0.483 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 3.329354e-01 | 0.478 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 3.344639e-01 | 0.476 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 3.344639e-01 | 0.476 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 3.344639e-01 | 0.476 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 3.409140e-01 | 0.467 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 3.417561e-01 | 0.466 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 3.417561e-01 | 0.466 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 3.473831e-01 | 0.459 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 3.473831e-01 | 0.459 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 3.479640e-01 | 0.458 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 3.489689e-01 | 0.457 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.489689e-01 | 0.457 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 3.489689e-01 | 0.457 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 3.489689e-01 | 0.457 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 3.489689e-01 | 0.457 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 3.489689e-01 | 0.457 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 3.528258e-01 | 0.452 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 3.533561e-01 | 0.452 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 3.533561e-01 | 0.452 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 3.533561e-01 | 0.452 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 3.533561e-01 | 0.452 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 3.561031e-01 | 0.448 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 3.561031e-01 | 0.448 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 3.561031e-01 | 0.448 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 3.593229e-01 | 0.445 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 3.607261e-01 | 0.443 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 3.646630e-01 | 0.438 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 3.701391e-01 | 0.432 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 3.725093e-01 | 0.429 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 3.725093e-01 | 0.429 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 3.770425e-01 | 0.424 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 3.770425e-01 | 0.424 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 3.770425e-01 | 0.424 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 3.803168e-01 | 0.420 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 3.803168e-01 | 0.420 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 3.822116e-01 | 0.418 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 3.834724e-01 | 0.416 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 3.838708e-01 | 0.416 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 3.838708e-01 | 0.416 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 3.842054e-01 | 0.415 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 3.901483e-01 | 0.409 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 3.906246e-01 | 0.408 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 3.973048e-01 | 0.401 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 3.973048e-01 | 0.401 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 4.034874e-01 | 0.394 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 4.039121e-01 | 0.394 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 4.039121e-01 | 0.394 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 4.039121e-01 | 0.394 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 4.039121e-01 | 0.394 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 4.039121e-01 | 0.394 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 4.039121e-01 | 0.394 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 4.039121e-01 | 0.394 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 4.059513e-01 | 0.392 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 4.104475e-01 | 0.387 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 4.104475e-01 | 0.387 | 1 | 1 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 4.104475e-01 | 0.387 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 4.169116e-01 | 0.380 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 4.169116e-01 | 0.380 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 4.169116e-01 | 0.380 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 4.187065e-01 | 0.378 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 4.187065e-01 | 0.378 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 4.212943e-01 | 0.375 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 4.221813e-01 | 0.375 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 4.221813e-01 | 0.375 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 4.233052e-01 | 0.373 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 4.233052e-01 | 0.373 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 4.233052e-01 | 0.373 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 4.233052e-01 | 0.373 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 4.233052e-01 | 0.373 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 4.299920e-01 | 0.367 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 4.328953e-01 | 0.364 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 4.328953e-01 | 0.364 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 4.337284e-01 | 0.363 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 4.358840e-01 | 0.361 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 4.358840e-01 | 0.361 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 4.358840e-01 | 0.361 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 4.374517e-01 | 0.359 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 4.415411e-01 | 0.355 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 4.420707e-01 | 0.355 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 4.420707e-01 | 0.355 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 4.420707e-01 | 0.355 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 4.448585e-01 | 0.352 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 4.476974e-01 | 0.349 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 4.481900e-01 | 0.349 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 4.481900e-01 | 0.349 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 4.481900e-01 | 0.349 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 4.481900e-01 | 0.349 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 4.481900e-01 | 0.349 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 4.481900e-01 | 0.349 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 4.542425e-01 | 0.343 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 4.602290e-01 | 0.337 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 4.720068e-01 | 0.326 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 4.724360e-01 | 0.326 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 4.835290e-01 | 0.316 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 4.835290e-01 | 0.316 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 4.835290e-01 | 0.316 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 4.846007e-01 | 0.315 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 4.891960e-01 | 0.311 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 4.891960e-01 | 0.311 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 4.891960e-01 | 0.311 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 4.891960e-01 | 0.311 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 4.891960e-01 | 0.311 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 4.891960e-01 | 0.311 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 4.948012e-01 | 0.306 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 5.003452e-01 | 0.301 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 5.003452e-01 | 0.301 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 5.003452e-01 | 0.301 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 5.020794e-01 | 0.299 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 5.058287e-01 | 0.296 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 5.058287e-01 | 0.296 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 5.112524e-01 | 0.291 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 5.123833e-01 | 0.290 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 5.123833e-01 | 0.290 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 5.166168e-01 | 0.287 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 5.166168e-01 | 0.287 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 5.191749e-01 | 0.285 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 5.212966e-01 | 0.283 | 1 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 5.219228e-01 | 0.282 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 5.259037e-01 | 0.279 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 5.271708e-01 | 0.278 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 5.271708e-01 | 0.278 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 5.271708e-01 | 0.278 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 5.323615e-01 | 0.274 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 5.323615e-01 | 0.274 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 5.374955e-01 | 0.270 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 5.374955e-01 | 0.270 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 5.374955e-01 | 0.270 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 5.425735e-01 | 0.266 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 5.475961e-01 | 0.262 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 5.489530e-01 | 0.260 | 0 | 0 |
| Translation | R-HSA-72766 | 5.524122e-01 | 0.258 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 5.525638e-01 | 0.258 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 5.574773e-01 | 0.254 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 5.585897e-01 | 0.253 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 5.623371e-01 | 0.250 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 5.623371e-01 | 0.250 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 5.662548e-01 | 0.247 | 1 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 5.671439e-01 | 0.246 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 5.680801e-01 | 0.246 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 5.712109e-01 | 0.243 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 5.743254e-01 | 0.241 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 5.766004e-01 | 0.239 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 5.766004e-01 | 0.239 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 5.766004e-01 | 0.239 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 5.766004e-01 | 0.239 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 5.774235e-01 | 0.239 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 5.812514e-01 | 0.236 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 5.812514e-01 | 0.236 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 5.812514e-01 | 0.236 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 5.812514e-01 | 0.236 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 5.812514e-01 | 0.236 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 5.812514e-01 | 0.236 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 5.835704e-01 | 0.234 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 5.858516e-01 | 0.232 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 5.858516e-01 | 0.232 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 5.896517e-01 | 0.229 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 5.904015e-01 | 0.229 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 5.904015e-01 | 0.229 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 5.904015e-01 | 0.229 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 5.993527e-01 | 0.222 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 6.017091e-01 | 0.221 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 6.037551e-01 | 0.219 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 6.055745e-01 | 0.218 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 6.124161e-01 | 0.213 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 6.124161e-01 | 0.213 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 6.124161e-01 | 0.213 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 6.124161e-01 | 0.213 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 6.148695e-01 | 0.211 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 6.162038e-01 | 0.210 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 6.208888e-01 | 0.207 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 6.219236e-01 | 0.206 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 6.289870e-01 | 0.201 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 6.291774e-01 | 0.201 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 6.332538e-01 | 0.198 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 6.372857e-01 | 0.196 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 6.412735e-01 | 0.193 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 6.412735e-01 | 0.193 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 6.414276e-01 | 0.193 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 6.452178e-01 | 0.190 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 6.452178e-01 | 0.190 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 6.452178e-01 | 0.190 | 0 | 0 |
| M Phase | R-HSA-68886 | 6.488300e-01 | 0.188 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 6.522149e-01 | 0.186 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 6.643013e-01 | 0.178 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 6.643013e-01 | 0.178 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 6.653362e-01 | 0.177 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 6.679937e-01 | 0.175 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 6.716457e-01 | 0.173 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 6.780585e-01 | 0.169 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 6.855023e-01 | 0.164 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 6.858586e-01 | 0.164 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 6.893151e-01 | 0.162 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 6.927339e-01 | 0.159 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 6.927339e-01 | 0.159 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 6.961152e-01 | 0.157 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 6.989439e-01 | 0.156 | 1 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 6.994596e-01 | 0.155 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 7.060389e-01 | 0.151 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 7.092746e-01 | 0.149 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 7.093056e-01 | 0.149 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 7.124749e-01 | 0.147 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 7.124749e-01 | 0.147 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 7.124749e-01 | 0.147 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 7.156402e-01 | 0.145 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 7.187708e-01 | 0.143 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 7.293690e-01 | 0.137 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 7.309543e-01 | 0.136 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 7.337420e-01 | 0.134 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 7.358751e-01 | 0.133 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 7.379937e-01 | 0.132 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 7.397462e-01 | 0.131 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 7.426129e-01 | 0.129 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 7.435711e-01 | 0.129 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 7.454481e-01 | 0.128 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 7.454481e-01 | 0.128 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 7.544288e-01 | 0.122 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 7.564820e-01 | 0.121 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 7.591653e-01 | 0.120 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 7.591653e-01 | 0.120 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 7.644441e-01 | 0.117 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 7.661685e-01 | 0.116 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 7.746589e-01 | 0.111 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 7.761022e-01 | 0.110 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 7.792493e-01 | 0.108 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 7.795999e-01 | 0.108 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 7.868101e-01 | 0.104 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 7.868101e-01 | 0.104 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 7.868101e-01 | 0.104 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 7.868101e-01 | 0.104 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 7.985176e-01 | 0.098 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 8.027348e-01 | 0.095 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 8.027348e-01 | 0.095 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 8.104270e-01 | 0.091 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 8.154393e-01 | 0.089 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 8.162821e-01 | 0.088 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 8.174761e-01 | 0.088 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 8.194906e-01 | 0.086 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 8.194906e-01 | 0.086 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 8.208890e-01 | 0.086 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 8.254024e-01 | 0.083 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 8.366545e-01 | 0.077 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 8.384585e-01 | 0.077 | 0 | 0 |
| S Phase | R-HSA-69242 | 8.402426e-01 | 0.076 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 8.437523e-01 | 0.074 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 8.471853e-01 | 0.072 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 8.471853e-01 | 0.072 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 8.505433e-01 | 0.070 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 8.554433e-01 | 0.068 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 8.586208e-01 | 0.066 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 8.601834e-01 | 0.065 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 8.662464e-01 | 0.062 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 8.662640e-01 | 0.062 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 8.662640e-01 | 0.062 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 8.706513e-01 | 0.060 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 8.803395e-01 | 0.055 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 8.893059e-01 | 0.051 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 8.941262e-01 | 0.049 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 8.964575e-01 | 0.047 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 8.987377e-01 | 0.046 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 9.009680e-01 | 0.045 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 9.048116e-01 | 0.043 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.133604e-01 | 0.039 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 9.143206e-01 | 0.039 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 9.242097e-01 | 0.034 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 9.400447e-01 | 0.027 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.413691e-01 | 0.026 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 9.439312e-01 | 0.025 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.440913e-01 | 0.025 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.456217e-01 | 0.024 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.481499e-01 | 0.023 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 9.492961e-01 | 0.023 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.504413e-01 | 0.022 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.504413e-01 | 0.022 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 9.525860e-01 | 0.021 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 9.541504e-01 | 0.020 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.649517e-01 | 0.015 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.697031e-01 | 0.013 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 9.771135e-01 | 0.010 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 9.835980e-01 | 0.007 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.871778e-01 | 0.006 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.888612e-01 | 0.005 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.897067e-01 | 0.004 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.914319e-01 | 0.004 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.928280e-01 | 0.003 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.932222e-01 | 0.003 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.992283e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.998702e-01 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.999210e-01 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 9.999286e-01 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 9.999949e-01 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | 0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.110223e-16 | 15.955 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.332268e-15 | 14.875 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 3.619327e-14 | 13.441 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 1.006972e-13 | 12.997 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 1.006972e-13 | 12.997 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 1.889600e-13 | 12.724 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 4.546363e-13 | 12.342 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 5.997425e-13 | 12.222 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 8.203438e-13 | 12.086 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 1.021294e-12 | 11.991 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 1.021294e-12 | 11.991 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.280975e-12 | 11.892 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 1.694200e-12 | 11.771 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 2.162381e-12 | 11.665 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 2.162381e-12 | 11.665 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 2.127742e-12 | 11.672 | 0 | 0 |
| Depurination | R-HSA-73927 | 2.744360e-12 | 11.562 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 2.702838e-12 | 11.568 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 2.702838e-12 | 11.568 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 3.328227e-12 | 11.478 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 3.328227e-12 | 11.478 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 4.349743e-12 | 11.362 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 4.349743e-12 | 11.362 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 5.434764e-12 | 11.265 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 5.434764e-12 | 11.265 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 8.365419e-12 | 11.078 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 8.365419e-12 | 11.078 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 1.030953e-11 | 10.987 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.151712e-11 | 10.939 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 1.546285e-11 | 10.811 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 1.546285e-11 | 10.811 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 1.682088e-11 | 10.774 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.691036e-11 | 10.772 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 2.759037e-11 | 10.559 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 4.769751e-11 | 10.322 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 5.687650e-11 | 10.245 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 5.865519e-11 | 10.232 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 6.314060e-11 | 10.200 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 8.014334e-11 | 10.096 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 8.599021e-11 | 10.066 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 9.472179e-11 | 10.024 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.045114e-10 | 9.981 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.538590e-10 | 9.813 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.799317e-10 | 9.745 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 2.196838e-10 | 9.658 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 2.099076e-10 | 9.678 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 2.836610e-10 | 9.547 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 2.836610e-10 | 9.547 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 3.949562e-10 | 9.403 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 5.044896e-10 | 9.297 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 5.795925e-10 | 9.237 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 5.476136e-10 | 9.262 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 6.317966e-10 | 9.199 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 6.645752e-10 | 9.177 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 6.650723e-10 | 9.177 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 8.688138e-10 | 9.061 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 8.500938e-10 | 9.071 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 8.688138e-10 | 9.061 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 8.866227e-10 | 9.052 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 9.131920e-10 | 9.039 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 1.056097e-09 | 8.976 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 9.906721e-10 | 9.004 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.127633e-09 | 8.948 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.555229e-09 | 8.808 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 1.708031e-09 | 8.768 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 1.708031e-09 | 8.768 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 1.861375e-09 | 8.730 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.708031e-09 | 8.768 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 2.179563e-09 | 8.662 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 2.368847e-09 | 8.625 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 2.546006e-09 | 8.594 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 2.996787e-09 | 8.523 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 3.363433e-09 | 8.473 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 3.363433e-09 | 8.473 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 3.423824e-09 | 8.465 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 3.769699e-09 | 8.424 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 4.716263e-09 | 8.326 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 6.039202e-09 | 8.219 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 8.195082e-09 | 8.086 | 0 | 0 |
| M Phase | R-HSA-68886 | 9.739930e-09 | 8.011 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 9.929919e-09 | 8.003 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.031889e-08 | 7.986 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 1.033196e-08 | 7.986 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.342769e-08 | 7.872 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.481685e-08 | 7.829 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 2.387502e-08 | 7.622 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 2.647322e-08 | 7.577 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 3.757359e-08 | 7.425 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 3.757359e-08 | 7.425 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 4.880911e-08 | 7.311 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 4.880911e-08 | 7.311 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 5.345856e-08 | 7.272 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 5.526692e-08 | 7.258 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 7.427488e-08 | 7.129 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 9.099634e-08 | 7.041 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.109227e-07 | 6.955 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 1.153629e-07 | 6.938 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.292118e-07 | 6.889 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 1.295839e-07 | 6.887 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 1.754484e-07 | 6.756 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 2.187532e-07 | 6.660 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 2.256608e-07 | 6.647 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 2.450833e-07 | 6.611 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 2.526431e-07 | 6.597 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 2.779245e-07 | 6.556 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 3.122032e-07 | 6.506 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 3.122032e-07 | 6.506 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 3.122032e-07 | 6.506 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 3.144543e-07 | 6.502 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 4.501521e-07 | 6.347 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 5.312299e-07 | 6.275 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 9.311802e-07 | 6.031 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 9.826326e-07 | 6.008 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.037992e-06 | 5.984 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.340108e-06 | 5.873 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.475811e-06 | 5.831 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.653583e-06 | 5.782 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 2.141180e-06 | 5.669 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 2.141180e-06 | 5.669 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 2.262875e-06 | 5.645 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 2.629542e-06 | 5.580 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 2.950606e-06 | 5.530 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 3.048259e-06 | 5.516 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 3.048259e-06 | 5.516 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 3.114162e-06 | 5.507 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 3.468913e-06 | 5.460 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 4.816116e-06 | 5.317 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 5.691077e-06 | 5.245 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 6.288897e-06 | 5.201 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 7.768222e-06 | 5.110 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 8.858575e-06 | 5.053 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.628440e-06 | 5.016 | 1 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 9.752111e-06 | 5.011 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.107836e-05 | 4.956 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.107836e-05 | 4.956 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.107836e-05 | 4.956 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.220549e-05 | 4.913 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.289099e-05 | 4.890 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.442239e-05 | 4.841 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 1.726519e-05 | 4.763 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.849271e-05 | 4.733 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.862320e-05 | 4.730 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 2.556052e-05 | 4.592 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 2.730808e-05 | 4.564 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 2.940759e-05 | 4.532 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 2.980076e-05 | 4.526 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 3.576801e-05 | 4.447 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 5.196274e-05 | 4.284 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 5.196274e-05 | 4.284 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 5.668823e-05 | 4.247 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 6.020500e-05 | 4.220 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 7.864491e-05 | 4.104 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 8.917309e-05 | 4.050 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.080458e-04 | 3.966 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.080458e-04 | 3.966 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.074901e-04 | 3.969 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.168199e-04 | 3.932 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.281265e-04 | 3.892 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 1.368955e-04 | 3.864 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 1.590493e-04 | 3.798 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.624310e-04 | 3.789 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.766233e-04 | 3.753 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.766233e-04 | 3.753 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.955989e-04 | 3.709 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 2.025123e-04 | 3.694 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 2.090004e-04 | 3.680 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 2.091524e-04 | 3.680 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 2.170437e-04 | 3.663 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 2.709444e-04 | 3.567 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 2.720248e-04 | 3.565 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 2.735752e-04 | 3.563 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 2.754343e-04 | 3.560 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 2.754343e-04 | 3.560 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 2.754343e-04 | 3.560 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 2.754343e-04 | 3.560 | 0 | 0 |
| Disease | R-HSA-1643685 | 3.119860e-04 | 3.506 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 4.345144e-04 | 3.362 | 1 | 0 |
| L1CAM interactions | R-HSA-373760 | 4.598873e-04 | 3.337 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 5.193170e-04 | 3.285 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 5.261728e-04 | 3.279 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 5.454213e-04 | 3.263 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 5.948621e-04 | 3.226 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 6.285108e-04 | 3.202 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 6.702711e-04 | 3.174 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 7.130206e-04 | 3.147 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 8.026952e-04 | 3.095 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 8.623998e-04 | 3.064 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.008214e-03 | 2.996 | 1 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 1.031617e-03 | 2.986 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 1.053455e-03 | 2.977 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.062605e-03 | 2.974 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 1.124406e-03 | 2.949 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 1.083798e-03 | 2.965 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 1.085478e-03 | 2.964 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 1.441362e-03 | 2.841 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.462345e-03 | 2.835 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.553374e-03 | 2.809 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.677533e-03 | 2.775 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 1.699222e-03 | 2.770 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.800704e-03 | 2.745 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.841969e-03 | 2.735 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 1.943823e-03 | 2.711 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 2.087345e-03 | 2.680 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 2.103306e-03 | 2.677 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 2.390353e-03 | 2.622 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 2.497291e-03 | 2.603 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 2.634101e-03 | 2.579 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 2.925479e-03 | 2.534 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 3.024140e-03 | 2.519 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 3.320081e-03 | 2.479 | 1 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 4.993840e-03 | 2.302 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 4.993840e-03 | 2.302 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 4.993840e-03 | 2.302 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 5.258447e-03 | 2.279 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 5.265229e-03 | 2.279 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 5.756840e-03 | 2.240 | 1 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 6.001761e-03 | 2.222 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 6.001761e-03 | 2.222 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 6.001761e-03 | 2.222 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 6.089502e-03 | 2.215 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 6.089502e-03 | 2.215 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 6.369788e-03 | 2.196 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 6.503441e-03 | 2.187 | 0 | 0 |
| Drug resistance of FLT3 mutants | R-HSA-9702506 | 1.031747e-02 | 1.986 | 0 | 0 |
| Drug resistance of KIT mutants | R-HSA-9669937 | 1.031747e-02 | 1.986 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 1.031747e-02 | 1.986 | 0 | 0 |
| KIT mutants bind TKIs | R-HSA-9669921 | 1.031747e-02 | 1.986 | 0 | 0 |
| FLT3 mutants bind TKIs | R-HSA-9702509 | 1.031747e-02 | 1.986 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 1.031747e-02 | 1.986 | 0 | 0 |
| sorafenib-resistant FLT3 mutants | R-HSA-9702624 | 1.031747e-02 | 1.986 | 0 | 0 |
| midostaurin-resistant FLT3 mutants | R-HSA-9702600 | 1.031747e-02 | 1.986 | 0 | 0 |
| Imatinib-resistant KIT mutants | R-HSA-9669917 | 1.031747e-02 | 1.986 | 0 | 0 |
| Nilotinib-resistant KIT mutants | R-HSA-9669926 | 1.031747e-02 | 1.986 | 0 | 0 |
| lestaurtinib-resistant FLT3 mutants | R-HSA-9702596 | 1.031747e-02 | 1.986 | 0 | 0 |
| KW2449-resistant FLT3 mutants | R-HSA-9702569 | 1.031747e-02 | 1.986 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 1.031747e-02 | 1.986 | 0 | 0 |
| tamatinib-resistant FLT3 mutants | R-HSA-9703009 | 1.031747e-02 | 1.986 | 0 | 0 |
| pexidartinib-resistant FLT3 mutants | R-HSA-9702605 | 1.031747e-02 | 1.986 | 0 | 0 |
| crenolanib-resistant FLT3 mutants | R-HSA-9702581 | 1.031747e-02 | 1.986 | 0 | 0 |
| semaxanib-resistant FLT3 mutants | R-HSA-9702577 | 1.031747e-02 | 1.986 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 1.031747e-02 | 1.986 | 0 | 0 |
| quizartinib-resistant FLT3 mutants | R-HSA-9702620 | 1.031747e-02 | 1.986 | 0 | 0 |
| linifanib-resistant FLT3 mutants | R-HSA-9702998 | 1.031747e-02 | 1.986 | 0 | 0 |
| Masitinib-resistant KIT mutants | R-HSA-9669924 | 1.031747e-02 | 1.986 | 0 | 0 |
| sunitinib-resistant FLT3 mutants | R-HSA-9702632 | 1.031747e-02 | 1.986 | 0 | 0 |
| Dasatinib-resistant KIT mutants | R-HSA-9669914 | 1.031747e-02 | 1.986 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 1.031747e-02 | 1.986 | 0 | 0 |
| ponatinib-resistant FLT3 mutants | R-HSA-9702614 | 1.031747e-02 | 1.986 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 1.031747e-02 | 1.986 | 0 | 0 |
| Regorafenib-resistant KIT mutants | R-HSA-9669929 | 1.031747e-02 | 1.986 | 0 | 0 |
| Sorafenib-resistant KIT mutants | R-HSA-9669936 | 1.031747e-02 | 1.986 | 0 | 0 |
| tandutinib-resistant FLT3 mutants | R-HSA-9702636 | 1.031747e-02 | 1.986 | 0 | 0 |
| gilteritinib-resistant FLT3 mutants | R-HSA-9702590 | 1.031747e-02 | 1.986 | 0 | 0 |
| Sunitinib-resistant KIT mutants | R-HSA-9669934 | 1.031747e-02 | 1.986 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 7.094421e-03 | 2.149 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 7.178429e-03 | 2.144 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 9.302496e-03 | 2.031 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.857817e-03 | 2.006 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 9.526648e-03 | 2.021 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 8.269985e-03 | 2.082 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 7.094421e-03 | 2.149 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 7.513833e-03 | 2.124 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.046883e-02 | 1.980 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.086263e-02 | 1.964 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 1.090904e-02 | 1.962 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 1.227618e-02 | 1.911 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 1.255398e-02 | 1.901 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.266147e-02 | 1.898 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.342186e-02 | 1.872 | 1 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.532914e-02 | 1.814 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 1.532914e-02 | 1.814 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.564792e-02 | 1.806 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 1.681692e-02 | 1.774 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 1.822092e-02 | 1.739 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 1.867204e-02 | 1.729 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 1.913347e-02 | 1.718 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 2.006648e-02 | 1.698 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 2.021043e-02 | 1.694 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 2.044813e-02 | 1.689 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.229185e-02 | 1.652 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 2.231780e-02 | 1.651 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 2.289085e-02 | 1.640 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 2.348919e-02 | 1.629 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 2.374561e-02 | 1.624 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.420163e-02 | 1.616 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 2.460462e-02 | 1.609 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 2.460462e-02 | 1.609 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 2.460462e-02 | 1.609 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 2.510245e-02 | 1.600 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.617593e-02 | 1.582 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 2.728984e-02 | 1.564 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 2.819711e-02 | 1.550 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.821323e-02 | 1.550 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 2.821323e-02 | 1.550 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 2.957580e-02 | 1.529 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 2.957580e-02 | 1.529 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 2.957580e-02 | 1.529 | 0 | 0 |
| Signaling by extracellular domain mutants of KIT | R-HSA-9680187 | 3.063602e-02 | 1.514 | 0 | 0 |
| Signaling by juxtamembrane domain KIT mutants | R-HSA-9669935 | 3.063602e-02 | 1.514 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 3.063602e-02 | 1.514 | 0 | 0 |
| Signaling by kinase domain mutants of KIT | R-HSA-9669933 | 3.063602e-02 | 1.514 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 3.063602e-02 | 1.514 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 3.075562e-02 | 1.512 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 3.090660e-02 | 1.510 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 3.195994e-02 | 1.495 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 3.247089e-02 | 1.489 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 3.257831e-02 | 1.487 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 3.440282e-02 | 1.463 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 3.440282e-02 | 1.463 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 3.468833e-02 | 1.460 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 3.603622e-02 | 1.443 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 3.620724e-02 | 1.441 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 3.620724e-02 | 1.441 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 3.696294e-02 | 1.432 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 3.696294e-02 | 1.432 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 3.734851e-02 | 1.428 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 3.848352e-02 | 1.415 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 3.848352e-02 | 1.415 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 4.063925e-02 | 1.391 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 4.063925e-02 | 1.391 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 4.063925e-02 | 1.391 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 4.063925e-02 | 1.391 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 4.063925e-02 | 1.391 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 4.063925e-02 | 1.391 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 4.063925e-02 | 1.391 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 4.063925e-02 | 1.391 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 4.063925e-02 | 1.391 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 4.063925e-02 | 1.391 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 4.063925e-02 | 1.391 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 4.063925e-02 | 1.391 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 4.167809e-02 | 1.380 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 4.309861e-02 | 1.366 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 4.533229e-02 | 1.344 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 4.626303e-02 | 1.335 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 4.660540e-02 | 1.332 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 4.660540e-02 | 1.332 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 4.660540e-02 | 1.332 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 4.688202e-02 | 1.329 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 4.706517e-02 | 1.327 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 5.053987e-02 | 1.296 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 5.053987e-02 | 1.296 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 5.057850e-02 | 1.296 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 6.033892e-02 | 1.219 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 7.003744e-02 | 1.155 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 7.963645e-02 | 1.099 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 8.913696e-02 | 1.050 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 8.913696e-02 | 1.050 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 8.913696e-02 | 1.050 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 9.853999e-02 | 1.006 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 9.853999e-02 | 1.006 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 6.822964e-02 | 1.166 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 8.618980e-02 | 1.065 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 9.853999e-02 | 1.006 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 6.822964e-02 | 1.166 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 7.003744e-02 | 1.155 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 7.963645e-02 | 1.099 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 5.437111e-02 | 1.265 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 7.963645e-02 | 1.099 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 6.822964e-02 | 1.166 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.267343e-02 | 1.033 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 7.112790e-02 | 1.148 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 6.033892e-02 | 1.219 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 8.772900e-02 | 1.057 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 1.021057e-01 | 0.991 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 7.003744e-02 | 1.155 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 8.913696e-02 | 1.050 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 9.246083e-02 | 1.034 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 5.134327e-02 | 1.290 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 7.963645e-02 | 1.099 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 7.963645e-02 | 1.099 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 8.913696e-02 | 1.050 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 5.705451e-02 | 1.244 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.021057e-01 | 0.991 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 8.005528e-02 | 1.097 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 6.273673e-02 | 1.202 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 6.251687e-02 | 1.204 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 7.675585e-02 | 1.115 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 6.255616e-02 | 1.204 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 7.704183e-02 | 1.113 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 5.531811e-02 | 1.257 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 8.005528e-02 | 1.097 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 6.524289e-02 | 1.185 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 9.859461e-02 | 1.006 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 5.437111e-02 | 1.265 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 7.406567e-02 | 1.130 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 6.104254e-02 | 1.214 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 8.622694e-02 | 1.064 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 8.618980e-02 | 1.065 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 9.886027e-02 | 1.005 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.021057e-01 | 0.991 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.030444e-01 | 0.987 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 1.076490e-01 | 0.968 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 1.078465e-01 | 0.967 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.083835e-01 | 0.965 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 1.153699e-01 | 0.938 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.153699e-01 | 0.938 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 1.170575e-01 | 0.932 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.170575e-01 | 0.932 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 1.170575e-01 | 0.932 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.170575e-01 | 0.932 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.170575e-01 | 0.932 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 1.170575e-01 | 0.932 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 1.170575e-01 | 0.932 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 1.170575e-01 | 0.932 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 1.187520e-01 | 0.925 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 1.221587e-01 | 0.913 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.261740e-01 | 0.899 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.261740e-01 | 0.899 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 1.261740e-01 | 0.899 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 1.261740e-01 | 0.899 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 1.287378e-01 | 0.890 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.296678e-01 | 0.887 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.296678e-01 | 0.887 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 1.343231e-01 | 0.872 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.351970e-01 | 0.869 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 1.351970e-01 | 0.869 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 1.351970e-01 | 0.869 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 1.351970e-01 | 0.869 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 1.390358e-01 | 0.857 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 1.441273e-01 | 0.841 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.466257e-01 | 0.834 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 1.529659e-01 | 0.815 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.529659e-01 | 0.815 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 1.529659e-01 | 0.815 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 1.535002e-01 | 0.814 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 1.535002e-01 | 0.814 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.573998e-01 | 0.803 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.573998e-01 | 0.803 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 1.617138e-01 | 0.791 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.617138e-01 | 0.791 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.617138e-01 | 0.791 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 1.617138e-01 | 0.791 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 1.617138e-01 | 0.791 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.659008e-01 | 0.780 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 1.683178e-01 | 0.774 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.703719e-01 | 0.769 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 1.703719e-01 | 0.769 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.703719e-01 | 0.769 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 1.703719e-01 | 0.769 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 1.703719e-01 | 0.769 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 1.789410e-01 | 0.747 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 1.789410e-01 | 0.747 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 1.789410e-01 | 0.747 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 1.789410e-01 | 0.747 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 1.789410e-01 | 0.747 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 1.789410e-01 | 0.747 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.789410e-01 | 0.747 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 1.789410e-01 | 0.747 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 1.867834e-01 | 0.729 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 1.874223e-01 | 0.727 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.874223e-01 | 0.727 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 1.874223e-01 | 0.727 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 1.874223e-01 | 0.727 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.874223e-01 | 0.727 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 1.874223e-01 | 0.727 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 1.874223e-01 | 0.727 | 0 | 0 |
| Translation | R-HSA-72766 | 1.883262e-01 | 0.725 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 1.905110e-01 | 0.720 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 1.958164e-01 | 0.708 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 1.958164e-01 | 0.708 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 1.958164e-01 | 0.708 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 1.979958e-01 | 0.703 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 2.001289e-01 | 0.699 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.041243e-01 | 0.690 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.041243e-01 | 0.690 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.041243e-01 | 0.690 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 2.041243e-01 | 0.690 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 2.041243e-01 | 0.690 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 2.123469e-01 | 0.673 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.123469e-01 | 0.673 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 2.123469e-01 | 0.673 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 2.123469e-01 | 0.673 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 2.204850e-01 | 0.657 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 2.204850e-01 | 0.657 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 2.204850e-01 | 0.657 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 2.204850e-01 | 0.657 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 2.207742e-01 | 0.656 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 2.244421e-01 | 0.649 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 2.282446e-01 | 0.642 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.285396e-01 | 0.641 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 2.285396e-01 | 0.641 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 2.285396e-01 | 0.641 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 2.285396e-01 | 0.641 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 2.303914e-01 | 0.638 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 2.320515e-01 | 0.634 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 2.325968e-01 | 0.633 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 2.365114e-01 | 0.626 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 2.365114e-01 | 0.626 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 2.365114e-01 | 0.626 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 2.425802e-01 | 0.615 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 2.444014e-01 | 0.612 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 2.444014e-01 | 0.612 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.444014e-01 | 0.612 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 2.444014e-01 | 0.612 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 2.444014e-01 | 0.612 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 2.522103e-01 | 0.598 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 2.522103e-01 | 0.598 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 2.522103e-01 | 0.598 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 2.522103e-01 | 0.598 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 2.522103e-01 | 0.598 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 2.522103e-01 | 0.598 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 2.522103e-01 | 0.598 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.536154e-01 | 0.596 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.549615e-01 | 0.594 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.549615e-01 | 0.594 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 2.555072e-01 | 0.593 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 2.563858e-01 | 0.591 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 2.599389e-01 | 0.585 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 2.599389e-01 | 0.585 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 2.599389e-01 | 0.585 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 2.599389e-01 | 0.585 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 2.599389e-01 | 0.585 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 2.599389e-01 | 0.585 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 2.664398e-01 | 0.574 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 2.664398e-01 | 0.574 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 2.675882e-01 | 0.573 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 2.675882e-01 | 0.573 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 2.675882e-01 | 0.573 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 2.675882e-01 | 0.573 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 2.675882e-01 | 0.573 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 2.675882e-01 | 0.573 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 2.740927e-01 | 0.562 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 2.751588e-01 | 0.560 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 2.751588e-01 | 0.560 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 2.751588e-01 | 0.560 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 2.751588e-01 | 0.560 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 2.751588e-01 | 0.560 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 2.751588e-01 | 0.560 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 2.758880e-01 | 0.559 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 2.779181e-01 | 0.556 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 2.814897e-01 | 0.551 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 2.826517e-01 | 0.549 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 2.826517e-01 | 0.549 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 2.826517e-01 | 0.549 | 0 | 0 |
| Protein folding | R-HSA-391251 | 2.855651e-01 | 0.544 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 2.900676e-01 | 0.538 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 2.900676e-01 | 0.538 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 2.970201e-01 | 0.527 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 2.974073e-01 | 0.527 | 0 | 0 |
| Iron assimilation using enterobactin | R-HSA-9638334 | 2.974073e-01 | 0.527 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 3.008328e-01 | 0.522 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 3.046715e-01 | 0.516 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 3.046715e-01 | 0.516 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 3.046715e-01 | 0.516 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 3.046715e-01 | 0.516 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 3.118611e-01 | 0.506 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 3.118611e-01 | 0.506 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 3.118611e-01 | 0.506 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 3.118611e-01 | 0.506 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 3.118611e-01 | 0.506 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 3.189767e-01 | 0.496 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 3.189767e-01 | 0.496 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 3.189767e-01 | 0.496 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 3.198398e-01 | 0.495 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 3.198398e-01 | 0.495 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 3.260193e-01 | 0.487 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 3.274100e-01 | 0.485 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 3.329894e-01 | 0.478 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 3.329894e-01 | 0.478 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 3.329894e-01 | 0.478 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 3.329894e-01 | 0.478 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.329894e-01 | 0.478 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 3.329894e-01 | 0.478 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 3.349580e-01 | 0.475 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 3.387230e-01 | 0.470 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 3.398879e-01 | 0.469 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 3.467155e-01 | 0.460 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 3.534728e-01 | 0.452 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 3.534728e-01 | 0.452 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 3.574467e-01 | 0.447 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 3.601607e-01 | 0.444 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 3.601607e-01 | 0.444 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 3.601607e-01 | 0.444 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 3.601607e-01 | 0.444 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 3.667798e-01 | 0.436 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 3.733308e-01 | 0.428 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 3.733308e-01 | 0.428 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 3.798145e-01 | 0.420 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 3.798145e-01 | 0.420 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 3.798145e-01 | 0.420 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 3.798145e-01 | 0.420 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 3.862315e-01 | 0.413 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 3.862315e-01 | 0.413 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 3.869942e-01 | 0.412 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 3.925825e-01 | 0.406 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 3.925825e-01 | 0.406 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 3.925825e-01 | 0.406 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 3.925825e-01 | 0.406 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 3.942910e-01 | 0.404 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 3.988681e-01 | 0.399 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 4.050891e-01 | 0.392 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 4.087653e-01 | 0.389 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 4.112461e-01 | 0.386 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 4.173397e-01 | 0.380 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 4.173397e-01 | 0.380 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 4.195112e-01 | 0.377 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 4.233707e-01 | 0.373 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 4.233707e-01 | 0.373 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 4.233707e-01 | 0.373 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 4.266203e-01 | 0.370 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 4.293396e-01 | 0.367 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 4.293396e-01 | 0.367 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 4.293396e-01 | 0.367 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 4.301580e-01 | 0.366 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 4.410937e-01 | 0.355 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 4.410937e-01 | 0.355 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 4.468803e-01 | 0.350 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 4.468803e-01 | 0.350 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 4.526072e-01 | 0.344 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 4.638849e-01 | 0.334 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 4.638849e-01 | 0.334 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 4.638849e-01 | 0.334 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 4.642345e-01 | 0.333 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 4.694368e-01 | 0.328 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 4.694368e-01 | 0.328 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 4.694368e-01 | 0.328 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 4.694368e-01 | 0.328 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 4.749316e-01 | 0.323 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 4.782647e-01 | 0.320 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 4.788181e-01 | 0.320 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 4.803698e-01 | 0.318 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 4.803698e-01 | 0.318 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 4.803698e-01 | 0.318 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 4.817759e-01 | 0.317 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 4.857520e-01 | 0.314 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 4.857520e-01 | 0.314 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 4.857520e-01 | 0.314 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 4.884418e-01 | 0.311 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 4.910788e-01 | 0.309 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 4.991550e-01 | 0.302 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 5.015684e-01 | 0.300 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 5.015684e-01 | 0.300 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 5.015684e-01 | 0.300 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 5.067324e-01 | 0.295 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 5.067324e-01 | 0.295 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 5.067324e-01 | 0.295 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 5.067324e-01 | 0.295 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 5.067324e-01 | 0.295 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 5.118431e-01 | 0.291 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 5.118431e-01 | 0.291 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 5.118431e-01 | 0.291 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 5.118431e-01 | 0.291 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 5.169012e-01 | 0.287 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 5.169012e-01 | 0.287 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 5.169012e-01 | 0.287 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 5.209590e-01 | 0.283 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 5.219072e-01 | 0.282 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 5.219072e-01 | 0.282 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 5.268617e-01 | 0.278 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 5.268617e-01 | 0.278 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 5.268617e-01 | 0.278 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 5.268617e-01 | 0.278 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 5.272963e-01 | 0.278 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 5.272963e-01 | 0.278 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 5.317651e-01 | 0.274 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 5.366962e-01 | 0.270 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 5.366962e-01 | 0.270 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 5.414208e-01 | 0.266 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 5.414208e-01 | 0.266 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 5.428916e-01 | 0.265 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 5.459679e-01 | 0.263 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 5.520773e-01 | 0.258 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 5.555346e-01 | 0.255 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 5.601426e-01 | 0.252 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 5.601426e-01 | 0.252 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 5.601426e-01 | 0.252 | 0 | 0 |
| Metal ion assimilation from the host | R-HSA-9638482 | 5.601426e-01 | 0.252 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 5.641229e-01 | 0.249 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 5.647030e-01 | 0.248 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 5.692165e-01 | 0.245 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 5.758446e-01 | 0.240 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 5.824797e-01 | 0.235 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 5.824797e-01 | 0.235 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 5.846430e-01 | 0.233 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 5.910955e-01 | 0.228 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 5.932182e-01 | 0.227 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 5.932182e-01 | 0.227 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 5.995345e-01 | 0.222 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 5.995345e-01 | 0.222 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 5.995345e-01 | 0.222 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 6.078005e-01 | 0.216 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 6.099733e-01 | 0.215 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 6.158967e-01 | 0.210 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 6.198824e-01 | 0.208 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 6.198824e-01 | 0.208 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 6.238269e-01 | 0.205 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 6.238269e-01 | 0.205 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 6.288555e-01 | 0.201 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 6.315943e-01 | 0.200 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 6.315943e-01 | 0.200 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 6.315943e-01 | 0.200 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 6.341192e-01 | 0.198 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 6.429474e-01 | 0.192 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 6.466539e-01 | 0.189 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 6.503222e-01 | 0.187 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 6.539527e-01 | 0.184 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 6.575457e-01 | 0.182 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 6.646207e-01 | 0.177 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 6.646207e-01 | 0.177 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 6.681036e-01 | 0.175 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 6.715505e-01 | 0.173 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 6.715505e-01 | 0.173 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 6.715505e-01 | 0.173 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 6.749618e-01 | 0.171 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 6.783379e-01 | 0.169 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 6.783379e-01 | 0.169 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 6.783379e-01 | 0.169 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 6.812530e-01 | 0.167 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 6.849859e-01 | 0.164 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 6.849859e-01 | 0.164 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 6.882585e-01 | 0.162 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 6.882585e-01 | 0.162 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 6.914973e-01 | 0.160 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 6.947026e-01 | 0.158 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 6.947026e-01 | 0.158 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 6.978748e-01 | 0.156 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 7.041214e-01 | 0.152 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 7.071963e-01 | 0.150 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 7.084057e-01 | 0.150 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 7.102395e-01 | 0.149 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 7.162318e-01 | 0.145 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 7.221121e-01 | 0.141 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 7.249902e-01 | 0.140 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 7.249902e-01 | 0.140 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 7.249902e-01 | 0.140 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 7.274893e-01 | 0.138 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 7.376306e-01 | 0.132 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 7.389942e-01 | 0.131 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 7.443952e-01 | 0.128 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 7.496852e-01 | 0.125 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 7.548663e-01 | 0.122 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 7.599408e-01 | 0.119 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 7.624387e-01 | 0.118 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 7.745461e-01 | 0.111 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 7.837888e-01 | 0.106 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 7.860400e-01 | 0.105 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 7.952029e-01 | 0.100 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 7.969512e-01 | 0.099 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 8.011592e-01 | 0.096 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 8.011592e-01 | 0.096 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 8.011592e-01 | 0.096 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 8.102795e-01 | 0.091 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 8.113037e-01 | 0.091 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 8.209337e-01 | 0.086 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 8.228002e-01 | 0.085 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 8.232110e-01 | 0.084 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 8.246474e-01 | 0.084 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 8.300749e-01 | 0.081 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 8.318467e-01 | 0.080 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 8.387522e-01 | 0.076 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 8.400888e-01 | 0.076 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 8.420985e-01 | 0.075 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 8.501652e-01 | 0.070 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 8.622283e-01 | 0.064 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 8.622283e-01 | 0.064 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 8.678927e-01 | 0.062 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 8.719885e-01 | 0.059 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 8.728069e-01 | 0.059 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 8.737183e-01 | 0.059 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 8.738536e-01 | 0.059 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 8.904810e-01 | 0.050 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 8.984067e-01 | 0.047 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.005207e-01 | 0.046 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 9.015613e-01 | 0.045 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 9.015613e-01 | 0.045 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 9.113901e-01 | 0.040 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.307903e-01 | 0.031 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.311785e-01 | 0.031 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.558178e-01 | 0.020 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.638649e-01 | 0.016 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.822366e-01 | 0.008 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.880162e-01 | 0.005 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.888769e-01 | 0.005 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.905204e-01 | 0.004 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 9.967826e-01 | 0.001 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.988431e-01 | 0.001 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 9.996652e-01 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 9.998555e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999781e-01 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 9.999996e-01 | 0.000 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 1.000000e+00 | 0.000 | 1 | 1 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 1.000000e+00 | 0.000 | 1 | 1 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 1.000000e+00 | 0.000 | 1 | 1 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
